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MALLINCKRODT INSTITUTE OF RADIOLOGY 
THE ART OF BREAST IMAGING 
At the Washington University Medical Center, radiologists 
and technologists provide a lifesaving breast-cancer 
screening program for women in the St. Louis area. 
12THE.^LIABILITY OF MRI 
A multicenter study is proving that magnetic resonance 
imaging techniques can noninvasively determine the 
malignancy or benignancy of adrenal masses. 
15 .j^RO^GC^CER^TteR^Y 
Radiation oncologists and cancer biologists combine efforts 
to improve treatments for patients with cancer. 
18 THE CHALLENGE OF MANAGED CARE AND 
N^AG^Co^EimON 
The proposed overhaul of the U.S. health-care system 
carries operational and cost-control challenges 
for all medical fields. 




| MALLINCKRODT | 
INSTITUTE OF RADIOLOGY | 
ON THE COVER: 
For every 100,000 women in the U.S., 27 will die as a result of breast 
cancer. Dr. Barbara Monsees, chief of the Institute's breast imaging 
section, and a team of radiologists and technologists want to reduce 





The results of a yearlong 
survey are in, and the second 
edition of The Best Doctors in 
America has listed eight 
Mallinckrodt Institute physi- 
cians as "the best and bright- 
est" in the medical profession. 
Based on an extensive nation- 
wide poll of thousands of 
medical specialists, the book 
lists 7,200 of the highest rated 
doctors nationwide, approxi- 
mately 2 percent of the 
nation's 350,000 practicing 
physicians. Over 350 speciali- 
ties are represented. 
According to the book's 
editors at the publishing 
house of Woodward/White, 
Inc., the listing is credible 
because the evaluation of 
the best doctors was made 
by other doctors in the same 
speciality. 
MIR physicians and their 
field(s) of expertise as 
reported in The Best Doctors 
of America are 
■ Perry W. Grigsby, M.D., 
professor of radiology and 
clinical chief of the Radiation 
Oncology Center, Barnes Hos- 
pital — radiation oncology: 
gynecologic cancer 
■ Tom R. Miller, M.D., 
Ph.D., professor of radiology 
— nuclear medicine: general 
nuclear medicine 
■ Robert J. Myerson, 
M.D., Ph.D., associate profes- 
sor of radiology — radiation 
oncology: hyperthermia 
■ Carlos A. Perez., M.D., 
professor of radiology and 
director of the Radiation 
Oncology Center — radiation 
oncology: breast cancer, geni- 
tourinary cancer, gynecologic 
cancer, and lung cancer 
■ Henry D. Royal, M.D., 
professor of radiology and 
associate director of the Divi- 
sion of Nuclear Medicine — 
nuclear medicine: general 
nuclear medicine, and radia- 
tion accidents and radiation 
injury 
■ Stuart S. Sagel, M.D., 
professor of radiology, chief 
of chest radiology, and 
cochief of body computed 
tomography — radiology: 
chest 
■ Barry A Siegel, M.D., 
professor of radiology and 
director of the Division of 
Nuclear Medicine — nuclear 
medicine: general nuclear 
medicine 
■ Todd H. Wasserman, 
M.D., professor of radiology 
and clinical chief of the Radia- 
tion Oncology Center, Jewish 
Hospital — radiation oncol- 
ogy: lymphomas. 
Evens Named 
to ACR Office 
In January, Ronald G. 
Evens, M.D., director of the 
Institute, was elected to a 
two-year term as vice-chair- 
man of the Board of Chan- 
cellors for the American 
College of Radiology (ACR). 
Evens, who in the fall of 
1993 was renamed to a sec- 
ond term as the Board's sec- 
retary-treasurer, will assume 
his new office in September 
of 1994. The24-member 
Board is the governing body 
of the ACR, determining 
policy standards for this 
national organization of 






P. Duffy Cutler, Ph.D., 
assistant professor of radiol- 
ogy, Division of Nuclear Medi- 
cine, and Ge Wang, Ph.D., 
assistant professor of radiol- 
ogy, Division of Radiology 
Research, each received a 
prestigious Biomedical Engi- 
neering Research Grant from 
The Whitaker Foundation. 
Cutler and coinvestigator 
Ming Xu, M.S., received fund- 
ing in the amount of $179,496 
for his research project "Clini- 
cally Viable 3-D PET Imaging 
of the Torso." Wang's 
$166,731 grant was awarded 
for his project on "Spiral CT 
of the Temporal Bone." Coin- 
vestigators for this grant are 
Michael Vannier, M.D., and 
Margaret Skinner, Ph.D., Divi- 
sion of Otolaryngology. 
The Foundation is a 
major source of funding for 
research and education in bio- 
medical engineering. Estab- 
lished in 1976 by U. A 
Whitaker, founder and chair- 
man of the board of the 
world's leading producer of 
electrical and electronic con- 
necting devices, the Founda- 
P. Duffy Cutler, Ph.D. (left) and 
Ge Wang, Ph.D. 
tion promotes research col- 
laboration among engineers, 
physical scientists, biologists, 
and physicians for the 
improvement of the quality of 
medicine. 
The Biomedical Engi- 
neering Research Grant Pro- 
gram was the first program 
initiated by the Foundation. 
The three-year awards were 
designed to help establish a 
scientific track for researchers 
who are in the early years of 
their career — doctorates 
must have been received less 
than eight years prior to sub- 
mitting a grant application, 
and medical-degree appli- 
cants may apply within seven 
years following completion oi 
their last residency. 
Research projects must 
address a significant biologi- 
cal or medical problem and 
may target either the under- 
standing of biological sys- 
tems or improvements in 
medical care. The grants are 
highly sought after, with 
more than 300 applications 
submitted for the 103 grants 
awarded in 1993. 






There are close to one 
million patients in the United 
States and Canada who are 
affected by the tremor, muscu- 
lar rigidity, and abnormal 
decrease in mobility and motor 
function associated with 
Parkinson's disease. These 
symptoms are caused by the 
degeneration of neurons deep 
within the brain; the degenera- 
tion subsequently leads to a 
deficiency of dopamine, which 
acts as a neurotransmitter in 
the central nervous system. 
Symptoms can be treated with 
an amino acid known as L- 
dopa, but the treatment causes 
involuntary muscle contrac- 
tions in many patients. 
Consequently, effective treat- 
ment is limited. 
As principal investigator, 
Joel S. Perlmutter, M.D., asso- 
ciate professor of neurology 
and radiology, received a 
$1,349,590 grant from the 
National Institute of Neuro- 
logical Disorders and Stroke 
to study the physiologic 
causes of L-dopa-induced 
involuntary movements and, 
subsequently, to provide 
improved drug therapy for 
parkinsonian patients. Using 
positron emission tomography 
(PET) and magnetic reso- 
nance imaging (MRI), Perl- 
mutter and his team of 
researchers will assess 
changes in the dopaminergic 
pathways as well as changes 
in regional cerebral blood 
flow. Dopaminergic receptor 
binding in vivo will be assayed 
using PET methods. 
Research team members 
include Stephen M. Moerlein, 
Ph.D., associate professor of 
radiology and biochemistry; 
Richard D. Todd, M.D., profes- 
sor of psychiatry; Lee W. Tem- 
pel, M.D., research instructor 
in neurology; Juanita L. Carl, 
M.S., research instructor in 
neurology; and Mokhtar H. Gado, 




Thomas E. Conturo, 
M.D., Ph.D., assistant profes- 
sor of radiology, Division of 
Radiology Research, received 
the 1993-1994 American Soci- 
ety of Neuroradiology 
(ASNR) Fellowship in Basic 
Science Research. The fel- 
lowship is awarded annually 
to a young investigator who 
is or has been working under 
the direction of a senior 
member of ASNR. Conturo's 
mentor is Daniel K. Kido, 
M.D., professor of radiology 
and chief of the Institute's 
neuroradiology section. 
Supported by a $35,000 
grant from Berlex Imaging, 
the one-year fellowship was 
established in 1986 by ASNR 
as a means to stimulate the 
scientific development of 
promising young researchers 
and to assist them in estab- 
lishing careers in academic 
radiology. Conturo received 
the ASNR fellowship for his 
proposed research on "Mech- 
anisms of the Phase Enhance- 
ment Effects of Bolus- 
Injected Paramagnetic Con- 
trast Agents and Applications 
in Quantitative Cerebral 
Blood Volume and Flow 
Imaging." 
E. Mark Haacke, Ph.D. 
Haacke 
Heads SMR 
As of January 1, E. Mark 
Haacke, Ph.D., professor of 
radiology and director of MR 
physicis, Division of Radiol- 
ogy Research, became the 
first president of the newly 
formed Society of Magnetic 
Resonance (SMR), a merger 
of the Society of Magnetic 
Resonance in Medicine and 
the Society for Magnetic 
Resonance Imaging. 
Haacke, the 1991-1992 
president of the Society for 
Magnetic Resonance Imag- 
ing, was instrumental in 
facilitating the merger. He 
served as a member of the 
Joint Merger Evaluation 
Committee that worked out 
the technical details for 
establishing SMR. Since 
September of 1993, Haacke 
has been interim president 
and stepped down at SMR's 
meeting in Dallas on March 7. 
An international scien- 
tific association, SMR is com- 
prised of over 3,600 
clinicians, physicists, engi- 
neers, and other scientists 
who are involved in the clini- 
cal and research applications 
of magnetic resonance imag- 
ing techniques. The Society 
provides a communication 
link among those clinicians 
and scientists as well as 
channels for continuing edu- 







Bruce L. McClennan, 
M.D., professor of radiology 
and chief of abdominal radi- 
ology, was the only radiolo- 
gist on the national panel that 
developed new guidelines for 
the diagnosis and treatment 
of benign prostate enlarge- 
ment. Doctors are now urged 
to use a more conservative 
approach to evaluate this 
common disorder that affects 
50 percent of the U.S. male 
population over the age of 60. 
As informed participants, 
patients are encouraged to 
become more involved in 
choosing a treatment 
method. The guidelines were 
released in early February by 
the Agency for Health Care 
Policy and Research, a divi- 
sion of the Department of 
Health and Human Services. 
With benign prostate 
enlargement, the prostate 
gland enlarges and restricts 
urine flow. More severe 
cases can lead to recurring 
urinary-tract infections and 
kidney damage. Also known 
as benign prostate hyperpla- 
sia (BPH), the disorder is 
usually treated surgically but 
can be treated with medica- 
tion or by physician follow-up. 
According to McClen- 
nan, the new guidelines may 
reduce the cost of diagnosis 
and treatment by advising 
physicians to use simple, 
inexpensive tests to evaluate 
potential BPH and to per- 
form additional tests only if 
necessary. 





As the first graduate stu- 
dent to work with Professor 
Leonard Tolmach, Dr. Robert 
Phillips was involved in the 
development of the mitotic col- 
lection method for obtaining 
synchronous populations of 
mammalian cells. This 
research provided the basis for 
future breakthroughs in stud- 
ies on irradiated cell survival 
and cellular repair. 
Phillips, guest speaker for 
the Second Annual Tolmach 
Lecture, has focused his 
research on the effects of drugs 
on radiation sensitivity during 
the cell cycle. His talk con- 
cerned "The Role of the 
Retinoblastoma Gene in Nor- 
mal Growth and Development." 
The Tolmach Lecture was 
established in 1992 in memory 
of renowned scientist Leonard 
J. Tolmach, Ph.D., professor 
emeritus of radiation biology 
in radiology, who died on 
November 26, 1991. The lec- 
ture is presented in conjunc- 
tion with the Annual 
Midwestern Regional Radia- 
tion Research Meeting held 
annually in November. 
Robert Phillips, Ph.D. 
Royal to Advise 
on Radiation 
Experiments 
Henry D. Royal, M.D., 
professor of radiology and 
associate director of the Divi- 
sion of Nuclear Medicine, was 
appointed by President Clin- 
ton as a member of the Advi- 
sory Committee on Human 
Radiation Experiments. The 
committee will investigate the 
ethical and scientific history 
of ionizing radiation experi- 
ments conducted from 1944 
to mid-1974. 
The President's action 
was prompted by allegations 
made in November of 1993 by 
a newspaper reporter in New 
Mexico, stating that patients 
who were uninformed about 
the risks of radiation expo- 
sure were injected with pluto- 
nium during experiments in 
the 1940s. Although the 
research had been conducted 
according to scientific investi- 
gation guidelines for that 
time, Department of Energy 
Secretary Hazel O'Leary rec- 
ommended that a full investi- 
gation be made. 
After a review of the 
experiments, the Advisory 
Committee will set ethical 
and scientific criteria for eval- 
uating the experiments in 
question and will determine if 
the testing was in compliance 
with those standards. The 
Committee also will recom- 
mend policies to ensure that 
current human radiation 
experiments are consistently 
conducted according to those 
set standards. 
The Advisory Commit- 
tee's final report will be made 
to the Human Radiation Inter- 
agency Working Group, com- 
prised of the secretaries of 
Energy, Defense, Health and 
Human Services, and Veterans 
Affairs; the Attorney General; 
the Administrator of the 
National Aeronautics and 
Space Administration; the 
Director of Central Intelli- 
gence; and the Director of the 
Office of Management and 
Budget. 
Royal's expertise in radia- 
tion exposure has earned 
international acclaim. At the 
request of the International 
Atomic Energy Agency 
(IAEA) and in cooperation 
with the former government 
of the Soviet Union, Royal 
performed an in-depth study 
of illnesses attributed to the 
1986 nuclear reactor explo- 
sion in Chernobyl. He was the 
co-leader of the IAEA's med- 
ical, effect team that travelled 
to Chernobyl in 1990. They 
conducted a health survey of 
inhabitants from both contam- 
inated and noncontaminated 
villages to determine the inci- 




Link to Dental 
Health 
Charles F. Hildebolt, 
D.D.S., Ph.D., associate pro- 
fessor of radiology, received a 
National Institute of Dental 
Research grant to investigate 
whether osteoporosis can 
result in loss of bone support- 
ing the teeth. 
The 150 women partici- 
pating in the study will 
receive free-of-charge 
■ annual dental examina- 
tions, cleanings, and X rays; 
■ calcium tablets; 
■ physical examinations 
and blood chemistry tests; 
■ annual examinations 
for osteoporosis; and 
■ mammograms, pap 
smears, and endometrial 
biopsies (based on medical 
history). 
Criteria for study 
participation: 
■ last menstrual period 24 
months prior to start of study, 
■ good health, 
■ no consumption of 
drugs that might affect bone 
matter, and 
■ have at least 10 natural 
teeth. 
The study is conducted u i 
collaboration with The Jewish 
Hospital Department of Den- 
tistry and Washington Univer 
sity's Department of 
Medicine, Division of Bone 
and Mineral Diseases. For 
more information, call Mary 
Dotson, Jewish Hospital Der 
tal Group, 314-454-5507. 
MALLINCKRODT INSTITUTE OF RADIOLOG' 
Most Prolific 
Reviewers 
In the February, 1994 
issue of Radiology, Stanley S. 
Siegelman, M.D., editor, paid 
tribute to the "corps of dedi- 
cated, unpaid reviewers" in a 
listing of the most prolific 
reviewers of manuscripts sub- 
mitted to the journal. Accord- 
ing to Radiology's statistics, 
1,010 scientists and physicians 
reviewed 17,974 manuscripts 
over the four-year period of 
July 1,1989, through June 30, 
1993. There were 18 MIR fac- 
ulty members among the 174 
reviewers who each prepared 
35 or more reviews: 
■ Dennis M. Balfe, M.D. 
■ Jeffrey J. Brown, M.D. 
■ Michael D. Darcy, M.D. 
■ Ronald G. Evens, M.D. 
■ E. Mark Haacke, Ph.D. 
■ Jay P. Heiken, M.D. 
■ Marshall E. Hicks, M.D. 
■ Bruce L. McClennan, M.D. 
■ William D. Middleton, 
M.D. 
■ Scott A. Mirowitz, M.D. 
■ Barbara S. Monsees, M.D. 
■ Daniel Picus, M.D. 
■ Stuart S. Sagel, M.D. 
■ Barry A. Siegel, M.D. 
■ Marilyn J. Siegel, M.D. 
■ Michael W. Vannier, M.D. 
■ Anthony J. Wilson, M.B., 
Ch.B. 
Cited for their consis- 
tently high quality of reviews, 
James A Brink, M.D., assistant 
professor of radiology, and 
Scott A Mirowitz, M.D., asso- 
ciate professor of radiology 
and radiologist-in-chief at Jew- 
ish Hospital, each received 
Radiology's "Editor's Recogni- 
tion Award for Special Distinc- 
tion in Reviewing." 
RTOG Clinical 
Trials 
As a member of the 
national cancer research orga- 
nization Radiation Therapy 
Oncology Group (RTOG), 
MIR's Radiation Oncology 
Center is participating in many 
clinical trials, providing treat- 
ment for patients with cancer. 
According to Bahman Emami, 
M.D., Washington University's 
RTOG principal investigator, 
many patients treated during 
clinical trials for cervical, 
esophageal, anal canal, lung, 
and prostate cancer have 
remained cancer free. Many 
of today's standard cancer 
treatments are based on 
results of past clinical trials. 
Less than 5 percent of 
adult cancer patients are 
treated as part of research 
studies. "If more adults partic- 
ipated in clinical trials, we are 
confident that the overall sur- 
vival rates would increase," 
says Emami. For further 





Ovarian cancer annually 
affects more than 20,000 
women in the United States, 
and more than 50 percent of 
those women will die as a 
result of the disease. There is 
no screening examination for 
ovarian cancer as there is the 
pap smear for cervical cancer 
or the mammogram for breast 
cancer. 
According to Arthur C. 
Fleischer, M.D., guest speaker 
for The First G. Leland Melson 
Visiting Professorship and 
Lecture on November 11, 
recent studies have provided 
good results in determining 
malignancy or benignancy in 
pelvic masses by using color 
Doppler sonography (CDS). 
In Fleischer's experience, CDS 
combined with CA-125 (a 
blood test for identifying ovar- 
ian cancer) produces a 91 per- 
cent diagnostic rate as 
compared to 82 percent with 
Arthur C. Fleischer, M.D., (left) and 
Bruce L McClennan, M.D. 
CA-125 alone. 
Known for his expertise 
in sonographic imaging, Fleis- 
cher, professor of radiology 
and radiological sciences and 
professor of obstetrics/gyne- 
cology at Vanderbilt Univer- 
sity School of Medicine, said, 
"It's difficult to have a high 
level of confidence based on 
morphology. With the CDS 
approach, the physician can 
go from morphology to look- 
ing at whether or not there is 
a tumor. CDS also is a useful 
tool for determining patients 
who may not need surgery." 
The Melson Visiting Pro- 
fessorship and Lecture was 
established in 1993 in honor 
of G. Leland Melson II, M.D., 
who was professor of radiol- 
ogy and chief of the Institute's 
clinical ultrasound at the time 
of his death on November 10, 
1992. He was instrumental in 
introducing color Doppler 
sonography to the Institute. 
FOCAL SPOT, SPRING, 1994 
An active member of breast-cancer screening committees at the city and 
state levels, Barbara Monsees, M.D., has been instrumental in developing 
the Institute's consistently high-quality breast imaging service. 
BARB 
ccording to statistics reported by the American Cancer 
Society, every 15 minutes three women develop breast cancer and 
one woman dies as a result of the disease.   Second only to lung 
cancer, more women in the United States die from breast cancer 
than from any type of cancer. These are disturbing facts, but the 
numbers of lives lost can be reduced. Mammography, a breast- 
cancer screening test, can detect cancer even before a mass can 
be felt. When breast cancer is diagnosed in its early stages, the 
prognosis is markedly improved: The death rate from breast 
cancer can be reduced by at least 30 percent for women who are 
screened as compared to a control group of 
women who are not screened. 
Across the nation, mammography is 
being recognized 
for   the   critical 
role it plays in women's health care. 
The number of women taking advan- 
tage of routine screening mammogra- 













^T^n August of 1993, Ronald 
^^W G. Evens, M.D., director 
of Mallinckrodt Institute, 
established a separate breast imag- 
ing section. Originally a part of 
musculoskeletal radiology, the new 
section now acts independently. 
Barbara S. Monsees, M.D., 
chief of breast imaging, heads up a 
six-member clinical team: Drs. 
Premsri Barton, Tracy Roberts, and 
Peter Shile, and a mammography 
fellow at Barnes Hospital; and Dr. 
Lawrence Kotner at Jewish Hospi- 
tal. These radiologists work close- 
ly with a staff of mammography 
technologists: Sharon Albertina, 
R.T., manager of radiology, who 
directs the entire technical staff; 
Roberta McQueen, R.T., supervisor 
of the mammography technologists 
at Barnes and Jewish hospitals; 
Linda Schubert, R.T., supervisor at 
Barnes West Hospital; and Chris- 
tine Focht, R.T., supervisor of the 
mobile mammography staff. The 
radiologists and technologists are 
a team with a common goal: sav- 
ing lives through the early detec- 
tion of breast cancer while 
providing quality care for women 
with symptoms that necessitate 
breast imaging. 
For women with no symptoms 
of breast cancer, screening mam- 
mography is performed on the 
mammography mobile unit, at the 
Mammography Screening Center, 
and at the Jewish Hospital mam- 
mography service. Patients with 
clinical problems, breast implants, 
or a prior history of breast cancer 
can have diagnostic mammography 
performed at the Breast Diagnostic 
Center at Barnes or at the Jewish 
Hospital mammography service. 
Collectively, nearly 150 mammo- 
grams are performed daily. 
With such a high volume of 
patients, an effective program 
must include teamwork and a 
mutual respect among radiologists 
and technologists. Monsees points 
out that a key factor in the success 
of the program is that all technolo- 
gists work exclusively in mammog- 
raphy, and are either specialty 
certified as mammographers or are 
in the certification process. As a 
result of the mammographer's 
familiarity with the technique, con- 
sistently high quality images are 
obtained. 
If images are poor, some can- 
cers may go undetected. In the 
Breast Imaging section, a series of 
checks and balances insures that 
achieving quality is a daily routine. 
Monthly meetings among Monsees; 
the radiology manager and supervi- 
sors; Michael Ward, R.T., M. Ed.; 
Barnes quality assurance manager; 
and Michael Ter-Pogossian, Ph.D., 
and Glenn Fletcher, Ph.D., 
Mallinckrodt Institute medical 
physicists, address policies, prob- 
lems, and solutions. 
"We not only review and inter- 
pret standards, we make certain 
that all standards are met and doc- 
umented. What we see as neces- 
sary to achieve quality films is 
accomplished," says Monsees. 
Diane Radford, M.D., Washing- 
ton University assistant professor 
of surgery and Barnes Hospital 
breast surgeon, frequently uses the 
services provided by the Breast 
Imaging section. "I rely on them 
very heavily," she says. "The quali- 
ty of mammography films and 
interpretations are very important. 
I can't use too many superlatives 
to describe their work." □ 
MALLINCKRODT INSTITUTE OF RADIOLOGY 
Ui^^-S^M^mmSSm^s^^^m^b.^ 
MIR RADIOLOGISTS CALL FOR A 
RADIOLUCENT BREAST IMPLANT FILLER 
y^^ugmentation mammo- 
Aw   -plasty, a breast- 
C_^/   %^/ enlargement 
procedure using a sealed silicone 
gel- or saline-filled prosthesis, has 
been available to women since the 
1960s. Since then, between 1 and 2 
million women have undergone 
breast augmentation, making it one 
of the most frequently performed 
procedures in plastic surgery. 
Weekly, as many as 10 women 
with augmented breasts come to 
one of the Medical Center's mam- 
mography facilities. Although 
screening mammography is the 
best diagnostic test for detecting 
clinically occult tumors in the 
unaugmented breast, implants are 
opaque to X rays and block 22 to 
83 percent of the breast tissue. 
In an attempt to better visual- 
ize the overlying breast tissue, 
mammographers obtain special 
views, called "pinch" or displace- 
ment views, where the breast 
tissue is pulled forward from 
the implant and selectively com- 
pressed, in addition to the stan- 
dard views. But even these do 
not afford the entire breast to be 
visualized. 
In 1987, Mallinckrodt Institute 
radiologists decided there had to 
be a better way. Prompted by 
Louis Gilula, M.D., chief of muscu- 
loskeletal radiology, a search 
began for a new, radiolucent 
breast implant filler. Gilula, Mon- 
sees, and former colleague Dr. 
Judy Destouet, asked Leroy 
Young, M.D., a Washington Univer- 
sity plastic surgeon, for his help in 
contacting implant manufacturers 
for collaboration on the research. 
When outside suppli- 
ers expressed little or no 
interest in the project, the 
research team went to 
John Eichling, Ph.D., the 
Institute's radiation safety 
officer. Pulling out the 
textbooks, Eichling calcu- 
lated the effective atomic 
number for breast tissue, 
based on the ratio of glan- 
dular fat in a normal 
breast. 
The atomic number of 
various substances is the 
chief determinant of the final 
image's character. Substances with 
high atomic numbers, such as the 
silicone gel used in most implants, 
are more opaque and block X rays 
almost as much as bone does. This 
opacity causes all tissue overlying 
the implant to be hidden on a mam- 
mogram. An implant filled with a 
material similar to the low effective 
atomic number of breast tissue was 
clearly needed. Eichling's search 
for naturally-occurring materials 
identified several possible candi- 
dates, including triglycerides such 
as peanut and sunflower oils. 
Subsequently, a medical manu- 
facturer provided experimental 
implants and testing began:   the 
implant shell alone; shells filled 
with either peanut oil or sunflower 
oil; shells filled with saline or sili- 
cone gel. X rays taken of each of 
the implants, which overlay a phan- 
tom simulating breast cancer 
masses and microcalcifications, 
provided positive results. The 
implants containing peanut oil or 
sunflower oil were radiolucent; 
the silicone-gel and saline fillers 
completely obscured mammogra- 
phy while the implant shell had 
little or no effect on resolution. 
With the help of AAV Com- 
pany, which investigates commer- 
cial outlets for Washington 
University research, Destouet, 
Eichling, Gilula, Monsees, and 
Young now hold the patent for a 
radiolucent breast implant filler. 
Lipo-Matrix, a Palo Alto, Califor- 
nia-based company formed 
through the cooperative efforts of 
AAV, is developing the implants 
and designing appropriate clinical 
trials. Research is in the preclinical 
stage, awaiting FDA approval. □ 





/W recent National Cancer 
t^/C/Institute (NCI) conference 
concluded that there is no proven 
benefit in annual or biannual raam- 
mography screening for women 
under 50 years of age. In a highly 
controversial act, the NCI removed 
its recommendation for routine 
screening mammography for 
women under age 50. The Ameri- 
can Cancer Society (ACS), the 
American College of Radiology, and 
the American Medical Association 
continue to recommend mammog- 
raphy screening for women over 
age 40. Although the NCI advises 
women to seek the advice of their 
FACILITY 
ACCREDITATION 
(0^"here are currently 12,000 
mammography units in 
the country. More than 50 per- 
cent of those units, including 
those at Barnes and Jewish hos- 
pitals and on the mammography 
van, participate in voluntary 
accreditation through the Ameri- 
can College of Radiology. In 
October of this year, the Mam- 
mography Quality Standards Act 
(MQSA), under the control of the 
Food and Drug Administration, 
will require that all mammogra- 
phy facilities be accredited 
For accreditation, mammog- 
raphy facilities must use dedi- 
cated mammography equipment, 
adhere to quality assurance pro- 
grams, hire qualified technologists 
and physicians, and submit images 
for review. Noncompliance could 
result in a fine of up to $10,000 for 
each failure or for each day a 
facility is noncompliant. □ 
personal physicians, its "Updating 
the Guidelines" report recom- 
mended mammography screenings 
for women 50 and older at one- or 
two-year intervals. 
"It's confusing to women. If 
experts in the American Cancer 
Society and NCI can't agree on 
guidelines, how will women decide? 
It leaves room for a lot of confusion 
and rightly so," says Monsees. "I 
fear that women will not be as com- 
pliant with ACS recommendations. 
A consequencewill be that some 
breast cancers will wait years to be 
detected, until they can be felt, and 
at that point it may be too late." 
NCI's report was based on an 
evaluation of eight studies con- 
ducted during the last 30 years. 
Many experts point out that the 
studies were flawed and do not 
have the statistical power to pro- 
vide proof even if it exists. Critics 
of the NCI lashed out that the rec- 
ommendation was impacted by cost 
factors. 
"I think the NCI's decision is 
important because it will eventually 
impact reimbursement for mammo- 
grams," Monsees says. "If the NCI 
doesn't recommend screening 
under age fifty, this will create a 
two-tiered system — women 
under fifty years of age who can 
afford to have screenings, and those 
who can't" 
Until the guidelines for screen- 
ing mammography are changed, 
Mallinckrodt Institute radiologists 
will continue to follow these 
recommendations: 
■ Ages 40 to 49 — Mammo- 
gram every one to two years, 
based on risk factors. 
■ Age 50 and up — Mammo- 
gram every year. 
Monsees recommends that 
women over age 40 have yearly 
mammograms. "Younger women 
tend to have faster growing tumors. 
For this reason, two years between 
screenings may be too long." □ 
DR. CELETTE 
SUGG SKINNER 
I^T^Pne ability to tap into 
^—*^F    Mallinckrodt Institute's 
t^S      data base of 86,000 
mammography screenings, which 
have been collected for over seven 
years, is like mining for gold to 
Celette Sugg Skinner, Ph.D., 
research instructor in radiology. 
Joining the breast imaging 
research team last fall, Skinner spe- 
cializes in public health and health 
behaviors but has a special interest 
in mammography screening utiliza- 
tion. Skinner's research of the 
effect of physician-to-patient mes- 
sage tailoring, conducted when she 
was at the University of North Car- 
olina at Chapel Hill, appeared in the 
January issue of the American 
Journal of Public Health. Interest 
in the topic has captured national 
media attention. 
"We knew that doctors' recom- 
mendations for screening were key 
predictors in whether patients fol- 
lowed through and had a mammo- 
gram," says Skinner. 
"We wanted to determine 
whether printed, tailored recom- 
mendations addressing women's 
specific screening and risk status 
and their perceptions about breast 
cancer and mammography made a 
difference," she adds. 
The results were that tailored 
physicians' recommendations did 
affect whether hard-to-reach popu- 
lations had mammograms. More 
African-Americans and low-income 
women who received tailored mes- 
sages went on to have mammo- 
grams than those who received a 
standard letter. 
With a master's degree in com- 
munications and having worked 
professionally in market research, 
Skinner's perspective in applying 
basic marketing techniques to 
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health care has made an impact. 
"The idea is to address issues of 
importance to individual women," 
she says. 
The goal of her research was to 
examine how to get women to con- 
tinue coming for mammograms by 
first understanding their beliefs and 
perceptions about breast cancer and 
mammography screening. Once 
behavior predictors are known, it is 
possible to develop a means of inter- 
vention in public health, says Skin- 
ner. This can be accomplished 
simply by an informational brochure 
or a mass screening program. 
Working with Maria Schmidt, 
M.D., and Thomas Pilgram, Ph.D., 
Skinner's goals for the Institute's 
data base are to explore whether 
factors such as the source of mam- 
mogram referral or women's experi- 
ences with 
the possibil- 















the years of 
data we have 
here. It's an 
interesting 
and important question — do 
women have different screening pat- 
terns because of their experiences? 
This will help us figure out how to 
get patients to come for screenings," 
says Skinner. 
While Skinner mines the data 
base for gold, somewhere up the 
road patients may reap the rewards 
of participating in a regular mam- 
mography screening program. □ 
Celette Sugg Skinner, Ph.D. 
DR. PETER SHILE 
eter E. Shile, M.D., 
assistant professor of 
radiology, comes to 
Mallinckrodt Institute from the Uni- 
versity of Pennsylvania where he 
completed fellowships in breast 
imaging and medical informatics. 
While interviewing for positions in 
breast imaging, he was particularly 
impressed with the quality care 
offered to women at the Institute's 
breast imaging services. He finds 
both the Breast Diagnostic Center 
and the Mammography Screening 
Center to be "extraordinarily com- 
prehensive and efficient." 
"I work with top-of-the-line 
equipment, an outstanding group of 
radiologists, and 
suberb technologists 
and support staff," he 
comments. 'This ser- 
vice offers high qual- 
ity exams and 
thorough patient 
tracking and follow- 
up. 
In addition to his 
clinical training, Shile 
brings training in 
radiological informat- 
ics to MIR's new 
breast imaging sec- 
tion. He defines his 
research interests as 
"the application of 
computers to infor- 
mation handling in 
radiology." A major portion of 
Shile's research training during his 
University of Pennsylvania fellow- 
ship involved a three-year, $5 mil- 
lion National Institutes of Health 
study to evaluate the effectiveness 
of a Picture Archiving and Commu- 
nications System (PACS). His work 
focused on evaluating the impact of 
PACS on the transmission of radio- 
logical information to intensive care 
units. 
Peter E. Shile, M.D. 
"Electronic communication of 
radiological information will almost 
certainly lead to more efficient 
patient care and, as a result, will play 
an important role in medicine as 
health-care reform advances," says 
Shile. 
One of the Institute's attractions 
for Shile was the large data base of 
information that has been collected 
for mammography screening. He 
and Barbara Monsees, M.D., section 
chief of breast imaging, hope to link 
this data base with the tumor reg- 
istries in Missouri and Illinois -a 
project that, according to Shile, 
would provide a complete source of 
data for doing outcome studies. 
The Electronic Radiology Labo- 
ratory (EEL), headed by G. James 
Blaine, D.Sc., was another of the 
Institute's attractions for Shile: "The 
ERL is a world-class center of exper- 
tise and is at the forefront of imple- 
menting and developing technologies 
for acquiring, storing, transmitting, 
and displaying radiological images in 
digital format." Through collabora- 
tion with ERL scientists, Shile hopes 
to improve diagnostic accuracy in 
mammography by developing new 
ways to process and display image 
information in mammograms. □ 
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THE ELIABILITY     OF 
BY      VICKI      KUNKLER 
ne of the first magnetic resonance imaging 
(MRI) scanners in the world arrived at 
Mallinckrodt Institute in the summer of 
1983. At that time, MRI was the newest of 
the imaging modalities, and Institute sci- 
entists were eager to investigate the technology. During the past 10 
years, MRI has proven to be a reliable tool for clinical and research 
applications. 
Under the direction of Jeffrey J. Brown, M.D., chief of the MRI 
section, the Institute now is leading a multicenter study that may 
provide patients who have adrenal masses with a noninvasive means 
for determining if the lesion is benign or malignant. Institute faculty 
are collaborating with researchers and clinicians from Georgetown 
University Medical Center, the University of North Carolina at 
Chapel Hill, New York University, the University of California at Los 
Angeles, and the University of Alabama at Birmingham. And accord- 
ing to Brown, the technique is working extremely well. 
Situated just above the kidneys, 
the adrenal glands are common 
sites for both benign and malig- 
nant lesions. Generally, clinicians 
have two options when an adrenal 
mass is discovered: biopsy under 
computed tomography (CT) guidance 
or following the patient while per- 
forming interval imaging studies. 
The lesion often cannot be 
ignored because of possible malig- 
nancy, says Brown, but the physician 
may be hesitant to pursue aggressive 
diagnostic methods, such as biopsy, 
because the majority of the lesions 
are benign. 
Although adrenal lesions usually 
are discovered incidentally on CT 
scans, computed tomography has lim- 
ited capabilities in characterizing 
these lesions. Histologically, adrenal 
lesions contain water and a large 
amount of fat, roughly 40 percent. 
Magnetic resonance further distin- 
guishes soft tissues: muscle, tendon, 
ligament, articular and fibroid carti- 
lage, fluid, blood, flowing blood, and, 
most importantly in the case of 
adrenal lesions, fat. 
Using no ioniz- 
ing radiation, mag- 
netic resonance 
imaging is based on 
interactions 
between a large 
magnetic field in the 
imaging equipment 
and the atoms in the 
human body. The 
imaging data in MRI 
is detected in a man- 
ner similar to the 
signal received by 
an ordinary radio 
with a receiver coil 
or antenna. The 
data is then 
processed by com- 
puter to produce the images. 
Brown points out that as far back 
as 1986 researchers were testing 
whether MRI could diagnose malig- 
nancy in adrenal lesions but because 
of small study population and older 
imaging techniques, the studies did 
not produce reliable results. "In the 
end, MR lost credibility for this type 
of study," he says. 
As an MR physicist, Debiao Li, Ph.D., develops 
data acquisition techniques so that magnetic reso- 
nance images contain high resolution, less image 
artifacts, and the best possible signal and contrast. 
n article authored by 
researchers at Thomas Jeffer- 
son University Hospital and 
Jefferson Medical College, which was 
published in the November 1992 issue 
of Radiology, renewed Brown's inter- 
est in MR imaging of the adrenal 
glands. The article advocated diagno- 
sis of adrenal lesions by chemical 
shift, or opposed-phase, imaging. By 
using this method, the imaging signal 
intensity from tissues is derived by 
subtracting the fat signal from the 
water signal. The article looked 
promising, says Brown. And since the 
Institute had joined the Body MR 
Research Group, comprised of acade- 
mic institutions that use magnets 
manufactured by Siemens Medical 
Systems, he would have the opportu- 
nity to study a larger population that 
could produce improved results. 
Under the direction of Jeffrey Brown, M.D., the Insti- 
tute's magnetic resonance imaging section includes the 
laboratory of clinical radiology, which provides for the 
coordination and support of all clinical diagnostic 
research programs. Brown also is program director for 
the Institute's research residency program. 
13 
THE    RELIABILITY    OF (Ml 
rrown also had another ace in 
the hole — MR Physicist 
Debiao Li, PhD., assistant pro- 
fessor of radiology, rounded out 
Brown's research team of Joseph A. 
Borello, M.D., assistant professor of 
radiology, and Kevin L. Shady, M.D., 
MR fellow. In August of 1993 a group 
of MR physicists, led by E. Mark 
Haacke, PhD., professor of radiology, 
was recruited from Case Western 
Reserve University in Cleveland in 
anticipation of the con- 
struction of the Insti- 
tute's new imaging 
research center. The 
center is slated for com- 
pletion in November of 
1994. The facility will be 
one of the best equipped 
centers worldwide 
where research will 
focus on the develop- 
ment and application of 
advanced MR tech- 
niques. These scientists 
have a broad range of 
research interests, including brain 
functional imaging, high resolution 
MR angiography, MR cardiopul- 
monary imaging, breast MR, fast imag- 
ing, general MR physics, and image 
reconstruction methods. 
According to Li, the physicist's 
role in basic science research relates 
to the study of the fundamental the- 
ory and mechanism behind MRI. In 
clinical research, the physicist devel- 
ops new MR techniques and modifies 
current techniques in order to meet 
the clinicians'needs. In the adrenal 
gland study, Li modified imaging tech- 
niques and optimized imaging para- 
meters so the diagnostic criteria could 
be achieved. He was able to obtain 
the best signal and contrast by manip- 
ulating the system software and over- 
saw image quality control and image 
evaluation. 
Figure 1 (left): Benign adrenal adenoma. 
(A) In-phase images shows a right adrenal 
mass (arrow) that is approximately isoin- 
tense with the liver. (6) On the opposed- 
phase image, the mass (arrow) is markedly 
hypointense as compared to the liver. 
Figure 2 (below): Adrenal metastasis. (A) 
In-phase image shows a left adrenal mass 
(arrow) with a signal intensity similar to 
that of the spleen. (B) Adrenal mass 
(arrow) remains equal in intensity with 
the spleen on the opposed-phase image. 
The black outlines around the adrenal mass 
and other structures are due to signal loss at 






 the techniques are 
^^^specific to the scanners," 
,%^says Li. "The companies 
are continuously improving both the 
hardware and the software for their 
scanners. In order to achieve success- 
ful research, it is important that MR 
physicists establish a good working 
relationship with companies like 
Siemens." 
The team members have 
examined 34 lesions at the 
Institute as well as 20 from 
the other institutions partici- 
pating in the study. To date, 
the group's success rate for 
identifying benign adrenal 
lesions is nearly 100 percent 
— on one scan, the lesion 
was too small to make a definitive 
diagnosis; on another, metal from a 
surgical clip obscured the image. 
Brown plans to include 200 patients, 
collectively, in the study. 
"Our goal is to have a reliable 
technique so that when an adrenal 
lesion is found, the patient won't 
need to go to biopsy or need to wait 
and see and worry. We can produce 
a reliable answer with MR," Brown 
says. □ 
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I m fi ffi 11 i n n Improving 
CANCER 
THERAPY 
he Mallinckrodt Institute of Radiology 
has long recognized that the birth of 
new treatment and diagnostic tools 
requires the marriage of researcher and 
clinician.   The year-old Human Tumor 
Cell Biology Program, which brings together cancer biologists and 
radiation oncologists, represents another such MIR union. Among the 
results of this potentially fruitful partnership are tests to predict more 
accurately how human tumors will respond to different therapies. 
Heading the program are researcher Joseph L. Roti Roti, Ph.D., 
associate director of the Radiation Oncoloy Center and chief of the 
cancer biology section, and clinician Todd H. Wasserman, M.D., 
chairman of the Radiation Oncology Center at Jewish Hospital. Par- 
ticipating in the cooperative venture are the entire cancer biology 
staff and clinicians from the Institute's Radiation Oncology Center 
and from Washington University School of Medicine's departments 
BY CLIFF FROEHLICH      of Surgery and Otolaryngology - Head and Neck Surgery. 
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THERAPY 
The seed for the joint project 
was planted by the biolo- 
gists. "It originated," Roti 
Roti explains, "because the cancer 
biology section had a program in 
place to better understand the way 
certain cellular structures and func- 
tional components relate to how 
tumor cells respond to therapeutic 
agents." Out of this project grew the 
Human Tumor Cell Biology Pro- 
gram, a broad-based approach to 
developing predictive assays: tests 
to measure, in Roti Roti's words, "a 
particular function that may exist in 
a tumor." 
The program is working on a 
multiplicity of assays, says Roti Roti: 
"We're investigating four or five dif- 
ferent DNA damage-and-repair 
assays, also assays for proliferation 
and for certain types of ontogenic 
transformation, or gene mutation. 
There are ten different protocols 
already written." 
Some of these assays, of course, 
will prove more practically applica- 
ble than others. In the best case sce- 
nario, an assay will have real clinical 
utility. "An assay could develop into 
a test that clinicians would routinely 
use, a test similar to the estrogen- 
receptor assay commonly used in 
breast cancer," says Wasserman. "If 
a patient had, say, X value on the 
test, then that would indicate a 
poorer or better prognosis, and 
treatment might be altered. Cer- 
tainly outcome can be predicted, 
and sometimes the option of altering 
treatment may improve that out- 
come." 
The program's broad scope 
—its simultaneous explo- 
ration of many assays — is 
one of its primary distinguishing fea- 
tures. According to Roti Roti, other 
trials take an assay and run with it. 
Although MIR doesn't necessarily 
have the definitive test, the 
researchers are looking for assays 
that ought to predict response based 
on biological principles. "Ours is a 
systematic approach," he says. 
"There are investigators who are 
conducting a trial of one assay, and 
they're studying it in hundreds of 
patients," Wasserman continues. 
"We've opted to stick to a more 
broad development of assays, not 
broad testing of a single assay. 
When we come up with an assay 
that we feel is really worthwhile, 
we'll be very happy to run with it vis 
a vis RTOG [Radiation Therapy 
Oncology Group, the radiation 
therapy national research groupJ." 
Wasserman points out that the 
Institute's methods for developing 
an assay are similar to those fol- 
lowed by companies. And, in fact, 
some of the work may end up being 
proprietary or patented or applica- 
ble to outside support. 
"This project is a 
way to translate 
cancer biology into 
clinical trials and 
eventually clinical 
practice." 
Potentially beneficial though 
the tests may prove, both 
Wasserman and Roti Roti 
emphasize that the development of 
new assays is not the sole benefit to 
be derived from the Human Tumor 
Cell Biology Program. The biolo- 
gists also gain additional informa- 
tion about tumor biology, 
streamlining techniques, and differ- 
ent ways of detecting important 
prognostic variables. 
One of Roti Roti's particular 
goals for the project is the scientific 
enhancement of future clinical trials. 
One of the differences Roti Roti 
hopes to achieve is the development 
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Left: Joseph L. Roti Roti, Ph.D. professor of radiology, 
also carries joint appointments at Washington Univer- 
sity as professor of cell biology and physiology and 
professor of biochemistry and molecular biophysics. 
Below: Todd Wasserman, M.D. is a recognized author- 
ity in the treatment of Hodgkin's disease and was 
instrumental in introducing to the St. Louis region the 
concept of stereotactic radiotherapy of brain tumors. 
of a hypothesis-driven clinical trial. 
Most clinical trials now are more 
empirical, he says, citing as exam- 
ples the failed hyperthermia and 
hypoxic-sensitizer trials. 
In these trials, no difference was 
seen between patients who were 
given an experimental treatment and 
those who were not. "So we 
achieved what is termed 'null 
hypothesis.' The patients weren't 
harmed by it, but the treatment had 
no effect," Wasserman explains. 
"One of the problems was that with 
such a heterogeneous population, 
the potential of seeing an effect was 
washed out. What we'd like to have 
seen was the ability to define in 
advance which patients would and 
would not benefit. Maybe then the 
trial would have been positive." 
Researchers hypothesize that 
the hypoxic-sensitizer trial may have 
failed because of the heterogeneous 
population, or because human 
tumors do not have the type of 
hypoxic-cell population tested, or 
because in human tumors 
MM  those hypoxic cells will not 
respond in the same way as 
rodent tumors respond. They 
also believe that the hyper- 
thermia trial may not have 
been successful because the 
tumor was not heated or 
because human cells are 
more resistant to heat than 
are rodent cells. 
With information 
provided by the 
Human Tumor Cell 
Biology Program, future trials 
should stand a better chance 
of success. "We'll try to find 
molecular markers," says Roti 
Roti. "For example, in hyper- 
thermia, we know that certain 
proteins are present when 
cells are more resistant to 
heat. We might ask the ques- 
tion of whether those pro- 
teins are present in the 
human tumor population that 
would figure into such a trial. 
Those kinds of questions are what 
this program is attempting to solve." 
Another of the unique aspects of 
the Human Tumor Cell Biology Pro- 
gram is hinted at in its name: its use 
of human tumors. "For the most 
part, biology research has tradition- 
ally been conducted using mouse 
tumors," Wasserman says. "There is 
a great deal of sameness between a 
human tumor and a mouse tumor. 
That sameness is good from the 
biologist's point of view because it 
affords the ability to work up an 
assay very cleanly, but it's not clean 
necessarily in the reality of life." 
"An assay could 
develop into a test 
that clinicans would 
routinely use... ." 
Roti Roti amplifies: "There are 
whole fields of treatment and modal- 
ity development that are compro- 
mised by the fact that all the work 
done previously was on mouse 
tumors. In hyperthermia, for exam- 
ple, the way rodent cells cope with 
heat stress is very different from the 
way human cells cope. Therefore, 
when a clinical trial is developed 
based on radiation-biology experi- 
ence, all of which is obtained from 
rodent cells and systems, it runs the 
risk of having a flawed rationale." 
ut Wasserman is quick to 
. point out that work with 
human tumors by no means 
devalues or eliminates experimenta- 
tion with rodents. "Tumor biology 
on rodent cells will continue," he 
says. "There are certain aspects in 
development for which the 
researcher cannot be dependent on 
human tumors to do the work." 
The project heads are pleased 
with the progress of the project thus 
far. "I'd say our goal in the first year 
or two was to get assays up and run- 
ning," says Wasserman. That 
accomplished, much still remains to 
be done. "This project is a way to 
translate cancer biology into clinical 
trials and eventually clinical prac- 
tice," adds Roti Roti. "The project's 
in phase one of the translation 
process." □ 
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Payment for health care in the U.S. 
has changed rapidly during the 
1980s, with the changes often 
identified by three-letter 
acronyms such as HMO, PPO, DRG, and KVS. 
Changes are likely to be even more rapid and 
fundamental in the next few years. Managed 
care and managed competition are the terms 
principally being used to describe these changes. 
In this overview, the goal is to present briefly the 
changes that have occurred, the changes we are 
likely to see, the implications of these changes for 
radiologists, and how radiologists can respond 
most effectively. 
The Changing World 
of Health Care Payments 
Conventionally, indemnity insurance payment as 
we knew it is already on the way to oblivion, 
with managed care replacing it. Managed care 
today comes in three broad forms that embody increas- 
ingly radical departures from the old model: 
■ What we'd call managed-conventional coverage in 
which patients or their physicians must obtain 
prior authorization for hospitalization and (increas- 
ingly) for expensive outpatient services, such as 
surgery or MRI. 
■ PPOs (preferred provider organizations), alterna- 
tively known as point of service (POS) arrange- 
ments. Under these, insurance typically pays in 
full, according to a negotiated fee schedule, if a 
patient uses a network or preferred physician or 
hospital but pays only 80 percent if the patient uses 
an outside provider. Purportedly, these networks 
were organized by selecting practitioners who are 
efficient in their practice patterns (use few tests, 
are slow to recommend surgery, etc.) and modest 
in their fees. In most cases, PPOs have tended to 
be a vehicle for obtaining discounted fees with lit- 
tle attention paid to practice patterns. 
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■HMOs (health maintenance organizations), in 
which a patient has no coverage unless he or she 
uses a doctor or hospital that is part of the HMO. 
HMOs come in two basic forms: the group or staff 
model in which salaried physicians are involved 
essentially full time with HMO patients, and the 
more open IPA (individual practice association), in 
which physicians maintain their own practices and 
see HMO patients as only part of their workload. 
The change to managed care is fueled by a desire 
to attack the problem of the rapidly rising cost of 
health care in the U.S. The pace of change is 
likely to accelerate as the Clinton Administration brings 
forth its solution — managed competition. Under 
managed competition, employees will have a choice 
among private health plans offering (more or less) stan- 
dardized benefit packages. Employees will make the 
choice on the basis of price and quality, with any cost 
above that of the least expensive plan being paid by the 
employee rather than the employer. Quality informa- 
tion will presumably include patient satisfaction and 
health outcomes data developed by the HIPC (health 
insurance purchasing cooperative) that will manage the 
system in each area. The Clinton plan is expected also 
to provide for coverage of all Americans, including a 
requirement that an employer provide coverage for all 
employees and dependents regardless of company size. 
Most likely, under managed competition, HMOs 
will come to cover a majority of the non-elderly popula- 
tion, as compared to the current 15 percent. Experi- 
ence with federal employees under arrangements 
similar to managed competition points to this predic- 
tion. The Clinton plan is expected also to include some 
form of global budget ceilings, which will create further 
pressure to contain increases in health-care spending. 
Moreover, even if no major legislation is enacted soon, 
employees will continue to seek nontraditional forms 
of managed care in an attempt to hold down their 
health-care costs. In short, we [radiologists] must 
expect that more and more of our work will take place 
under payment systems that are decidedly different 
from the indemnity fee-for-service system we have 
become accustomed to. Indeed, Clinton advisors 
expect that even managed conventional care (for exam- 
ple, self-insured large corporations) will become a van- 
ishing arrangement, with PPOs and HMOs covering all 
but a small percentage of nonelderly patients. Cur- 
rently, it appears that Medicare will remain in place as 
a health-care system for the elderly, but there will be 
increasingly stringent cost controls. 
Implications for Radiologists 
The implications of these changes should generally 
be favorable to radiology by radiologists. As a 
profession we have emphasized good quality at 
moderate cost and the elimination of waste, as in self- 
referral. However, there will be serious problems as 
philosophy becomes reality. For example, cost will 
probably be emphasized over quality because cost is 
easier to measure; pressures on costs will be continu- 
ous even after major savings have been achieved; and it 
is easy to predict there will be more competition among 
radiology groups. 
More specifically, the implications of payment sys- 
tem changes for radiologists will be the consequences 
of what happens with payers. Our predictions: 
Ronald G. Evens, M.D. 




■ Rapidly dwindling numbers of insurers who pay 
billed charges. 
■ Growth of PPOs and HMOs. 
■Increasing pressure on prices by PPOs, i.e., 
demands for greater discounts. 
■ In order for PPOs to remain competitive, they will 
develop a greater ability to steer patients away 
from practices and hospitals that don't agree to 
their terms, e.g., requiring patients to pay 40 per- 
cent or more of charges of non-network providers. 
■All payers will increasingly use data bases to iden- 
tify practice patterns in order to profile physicians 
and to institute practice guidelines. 
■ HMOs will change to meet the organizational 
demands of rapid growth, e.g., 
■A desire to contract with one entity, typically a 
large multi-specialty group or a large primary care 
practice, for all physicians' services in a geo- 
graphic area. Where the contract is with a pri- 
mary care practice, that practice will turn around 
and subcontract specialty care, including radiol- 
ogy (preferably with a single low bidder). 
■Increasing insistence on capitation (rather 
than modified fee-for-service) as the method of 
contracting. 
■ Increasing insistence that the HMO physicians 
practice in the hospitals the HMO has selected 
and on the HMO's terms. 
How Radiologists Can Respond 
As with previous changes in our profession, we 
should respond in a way that is helpful to our 
patients as well as to radiologists. An effective 
response should involve actions on several fronts and 
should include activity by individual radiology practices 
as well as by the ACR [American College of Radiology] 
and state radiologic societies. Fundamental issues we 
must jointly address: 
■ Self-referral generates excessive utilization and 
costs as well as undercutting radiologists. It is time 
to take action not only on joint ventures (physi- 
cians referring to outside facilities in which they 
have a financial interest) but also on nonradiolo- 
gists performing radiologic studies. 
■ Given the cost pressures that are likely in all set- 
tings, practice efficiency has to be high. 
■ Capitation contracts or other departures from fee- 
for-service are likely to make the increasing volume 
of imaging performed by radiologists (previously 
considered a major plus for our profession) into 
something of a problem. Under capitation, more 
volume means radiologists do more work and have 
more practice costs for the same revenue. To 
address this problem, the College [ACR] is devel- 
oping patient-care guidelines — a set of algo- 
rithms identifying the appropriate and economical 
diagnostic imaging procedures to be used for a 
patient, given the patient's presenting condition. 
These guidelines will enable radiologists to consult 
with referring physicians and point out what stud- 
ies are appropriate rather than largely following 
orders for specific studies. Development of a set of 
guidelines can do much to strengthen the argument 
for radiology by radiologists and the argument that 
radiologists rather than primary-care gatekeepers 
should decide on what imaging studies are per- 
formed. Such guidelines will be selling points to be 
used in negotiations with individual HMOs and 
PPOs. However, using the guidelines effectively 
will require radiologists to interact in a more active 
way with referring physicians. 
Negotiating managed-care contracts is a complex 
and difficult activity. Advice to bear in mind: 
■ Contracting is time-consuming and, with the health- 
care sysytem changing, contracting is constantly 
changing. Don't short-change the time and effort 
required to negotiate and to manage large contracts 
since these can affect major parts of a practice. 
■At least at the start, stay with short-term agree- 
ments as a trial of the population. It is hard to pre- 
dict how much care a population will require. It 
varies from one group to another, and the man- 
aged-care entity may not have good data initially. If 
possible, write stop-loss agreements into the con- 
tract so that if actual utilization differs from 
expected by more than a certain amount (say 10 
percent), payments are adjusted. Also, it will be 
necessary to count utilization by RVUs [relative- 
value unit] and separately by different types of pro- 
cedures, so a chest X ray and a CT study will not 
count as the same in any analysis. 
■ Keep good data on the utilization actually encoun- 
tered. In particular, maintain accurate records of 
the data as this will be the basis for developing 
internal financial statistics for use in negotiating. 
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■ Be responsive to the demands of managed-care 
organizations in proportion to the extent they can 
actually deliver (or move away) patients. As noted, 
most PPOs currently have relatively limited ability 
to move patients. 
■ Aim for diversification. Becoming heavily depen- 
dent on one managed-care organization makes a 
practice more susceptible to pressure from it. 
Larger radiology groups or cooperation with other 
groups will be essential to meet the needs of man- 
aged-care organizations. In larger urban areas, 
managed-care organizations will typically want to offer 
services at more than one hospital and at several ambu- 
latory sites, but they (or their principal physician 
group) will increasingly want to contract with only one 
radiology entity. The challenges will be particularly 
intense for solo or small-group practices located in rel- 
atively large population centers. We predict that the 
practice of medicine will undergo consolidation as has 
occurred recently in the airline industry. 
Cooperative working arrangements with the affili- 
ated hospital will become more important. Hospitals 
will be seeking managed-care contracts energetically 
and will be in no mood to have features of their exclu- 
sive contracts with hospital-based physicians become 
significant barriers to obtaining these contracts. Joint 
physician-hospital organizations (PHOs), built around a 
hospital's medical staff, may become a form of man- 
aged-care organization that offers physicians and hospi- 
tals a greater role and more rewards than do traditional 
managed-care organizations. Support of and involve- 
ment in PHOs will be a promising avenue for radiolo- 
gists and other physicians. However, there are three 
cautions: 
■ Putting together a successful managed-care 
organization requires a good deal of skill and 
investment. 
■ If the hospital and physician partners insist on all 
the rewards of fee-for-service, the PHO will not 
succeed in a cost-competitive environment. 
■ Beware of the hospital-dominated PHO. Physi- 
cians should have a strong role in the governance 
of PHOs. 
The speed and extent of changes will depend on 
local conditions. For example, if there is only one radi- 
ology group in an area and only one hospital in that 
area, competitive pressures will be much less than 
where radiology groups and hospitals are numerous. 
Jonathan H. Sunshine, Ph.D. 
But beware! Aggressive provider groups will be look- 
ing for high-cost geographic locales as green pastures. 
And managed-care organizations may import physi- 
cians to an area if they cannot work out satisfactory 
arrangements with local physicians. 
Overall, we clearly face a period of major changes 
and pressures in health-care financing arrangements 
over the next few years. At this time, there are no 
quick, easy answers for radiologists, and the promised 
federal comprehensive reform plan will only make the 
situation more fluid — at least, temporarily. 
Ronald G. Evens, M.D., director of Mallinckrodt 
Institute of Radiology, is secretary-treasurer and the 
elected vice-chairman of the ACR Board of Chancel- 
lors. Jonathan H. Sunshine, Ph.D., is director of 
research for the ACR. This article is an edited ver- 
sion of a newsletter Drs. Evens and Sunshine pub- 
lished for ACR members. A revised version will be 
published in an upcoming volume of the American 
Journal of Radiology. 




Harold F. Bennett, M.D., 
Ph.D., assistant professor of 
radiology, Division of Diag- 
nostic Radiology. 
Kim A. Deal, Ph.D., 
research associate, Division 
of Radiation Sciences. 
Jeffrey A. Dobkin, M.D., 
assistant professor of radiol- 
ogy, Division of Nuclear 
Medicine. 
Shantanu V. Kaushikkar, 
M.S., research associate, 
Division of Radiology 
Research. 
Steven E. Petersen, Ph.D., 
associate professor of radiol- 
ogy, Division of Radiation 
Sciences. 
Yuming Yin, M.D., research 
assistant in radiology, Divi- 
sion of Diagnostic Radiology. 
Yimin Zhu, D.Sc, research 
associate, Radiation Oncol- 
ogy Center. 
Darryl A. Zuckerman, 
M.D., assistant professor of 
radiology, Division of Diag- 
nostic Radiology. 
PROMOTIONS 
Ming-shun Chen, Ph.D., 
was promoted to instructor 
in radiology, Radiation 
Oncology Center. 
Ge Wang, Ph.D., was pro- 
moted to assistant professor 
of radiology, Division of 
Radiology Research. 
PROMOTIONS 
& CHANGE IN 
STATUS 
Keith C. Fischer, M.D., 
was promoted to associate 
professor of radiology, Divi- 
sion of Nuclear Medicine, 
and appointed as a full-time 
staff member. 
Lawrence M. Kotner, Jr., 
M.D., was promoted to asso- 
ciate professor of radiology, 
Division of Diagnostic Radi- 
ology, and appointed as a 
full-time staff member. 
Scott A. Mirowitz, M.D., 
was promoted to associate 
professor of radiology, 
named chief of radiology, 
Jewish Hospital, Division of 
Diagnostic Radiology, and 
appointed as a full-time staff 
member. 
William R. Reinus, M.D., 
was promoted to associate 
professor of radiology, Divi- 
sion of Diagnostic Radiol- 
ogy, and appointed as a 
full-time staff member. 
Joseph L. Roti Roti, Ph.D., 
was named to a joint appoint- 
ment as professor of cell 
biology and physiology and 
as professor of biochemistry 
and molecular biophysics. 
OFF STAFF 
Venkata R. Devineni, 
M.D., associate professor of I 
radiology, Radiation Oncol- 
ogy Center, has accepted the I 
position of chief of radiation I 
oncology, DePaul Health 
Center, St. Louis. 
Paul W. K. Luk, M.S., 
research instructor, Division I 
of Nuclear Medicine, com- 
pleted a one-year appoint- 
ment and has returned to 
Siemens/CTI in Knoxville, 
Tennessee. 
Vivek Mishra, Ph.D., 
research associate, Radia- 
tion Oncology Center, has 
accepted a position at 
Thomas Jefferson Univer- 
sity, Philadelphia. 
VISITING PROFESSORS 
& INVITED LECTURERS 
Dennis M. Balfe, M.D., 
professor of radiology, pre- 
sented "CT Evaluation of 
Hepatic Lesions: Dynamic 
Spiral Scans, CT Arteriopor- 
tography - How to Get the 
Most Out of Your CT 
Request" at the Refresher 
Course and Update in Gas- 
trointestinal Surgery, Wash- 
ington University School of 
Medicine, St. Louis, March 
10 and 11. 
James A. Brink, M.D., 
assistant professor of radiol- 
ogy, spoke on "Spiral Com- 
puted Body Tomography: 
Applications in the Chest 
and Abdomen" at the City- 
Wide Radiology Conference, 
St. Louis, December 13. He 
lectured on "Spiral CT" at 
the Greater St. Louis Society 
of Radiologists' meeting, St. 
Louis, January 18. Brink 
spoke on "CT Angiography" 
at the New York Roentgen 
Society meeting, New York, 
January 24. As visiting pro- 
fessor, Brink presented "Spi- 
ral CT of the Chest and 
Abdomen" at New York Uni- 
versity, New York, January 
25. He lectured on "Radio- 
logic Imaging in Diagnosis 
and Management of Acute 
Pancreatitis" at the 
Refresher Course and 
Update in Gastrointestinal 
Surgery, Washington Univer- 
sity School of Medicine, St. 
Louis, March 10 and 11. 
Brink participated in the 
Cross Sectional Angiography 
Workshop at the Society of 
Cardiovascular and Interven- 
tional Radiology meeting, 
San Diego, March 20. He 
presented "Spiral CT 
Overview" at the Orange 
County Radiological Soci- 
ety's meeting, Orange 
County, California, March 
22. As visiting professor, 
Brink spoke on "CT of the 
Peritoneal Ligaments" at the 
University of California at 
Irvine, March 22. 
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Patrick D. Datoc, M.D., 
I instructor in radiology and a 
1 fellow in magnetic reso- 
j nance imaging, spoke on "3D 
j Fat-Suppressed Breathhold 
I Imaging of the Kidneys" at 
| the Society of Magnetic Res- 
onance Imaging, Dallas, 
\ March 8. 
Bahman Emami, M.D., 
FACR, professor of radiol- 
ogy and associate director 
1 for research, Radiation 
j Oncology Center, as invited 
i speaker, presented "Head 
i and Neck Cancer. The 
| Mallinckrodt Experience: 
j 3D CRT for Head and Neck 
j Cancers" at the The Twenty- 
1 Ninth Annual San Francisco 
] Cancer Symposium, Wash- 
J ington, D.C., February 26 
I and 27. 
E. Mark Haacke, Ph.D., 
professor of radiology, 
spoke on "Applications of 
Contrast Agents to MRA and 
Cardiovascular Imaging" at 
Mallinckrodt Medical, Imag- 
ing Division, St. Louis, 
December 7. He presented 
"Recent Advances in MRA 
and Cardiovascular Imaging" 
at the University of Illinois, 
Urbana-Champaign, Decem- 
ber 8. Haacke also spoke on 
"Image Reconstruction and 
Post Processing Problems in 
MRI" at the University of 
Erlangen, Germany, Decem- 
ber 13. 
,  Jay P. Heiken, M.D., pro- 
fessor of radiology and 
(cochief of body computed 
tomography, as moderator, 
■  |  presided over the plenary 
session on "MRI of the 
I Abdomen and Pelvis" at the 
j j   12th Annual Meeting of the 
Society for Magnetic Reso- 
)  nance Imaging, Dallas, 
March 7. 
Myles B. Koby, M.D., 
instructor in radiology and a 
fellow in neuroradiology, 
presented "Cerebral Palsy: 
MRI Changes with Clinical 
Correlation in 236 Patients" 
at the Section on Pediatric 
Neurological Surgery, 22nd 
Annual Meeting of the Amer- 
ican Association of Neuro- 
logical Surgeons, San 
Antonio, December 10. 
Benjamin C. P. Lee, M.D., 
associate professor of radiol- 
ogy, presented "MRI Fea- 
tures of Spastic Diplegia and 
Quadriplegia at the Current 
Concepts of Cerebral Palsy 
Following Premature Birth 
Seminar, St. Louis, Novem- 
ber 19 and 20. 
Henry K. Lee, M.D., 
instructor in radiology, 
spoke on "Chemoradiation 
for Gastrointestinal Tumors" 
at the Refresher Course and 
Update in Gastrointestinal 
Surgery, Washington Univer- 
sity School of Medicine, St. 
Louis, March 10 and 11. 
Bruce L. McClennan, 
M.D., professor of radiology 
and chief of abdominal imag- 
ing, lectured on "Staging 
Renal Cell Cancers — Imag- 
ing Requirements" at Urol- 
ogy Grand Rounds, 
Washington University 
School of Medicine, St. 
Louis, February 5. He spoke 
on "Problem Cases in Renal 
CT" at the Sun Valley Imag- 
ing Symposium, Sun Valley, 
Idaho, March 3 and 4. 
McClennan presented "Con- 
trast Media Reaction Update 
1994," "Imaging the 
Retroperitoneum - Idiopathic 
Retroperitoneal Fibrosis and 
Lymphadenopathy," and 
"Staging Renal Cell Carci- 
noma — Imaging Armamen- 
tarium 1994" at the 
University of California, 
Diagnostic Course, San Fran- 
cisco, March 22. 
Ali S. Meigooni, Ph.D., 
assistant professor of radiol- 
ogy, as visiting professor, 
presented "Nuclear Data 
Base Development for Med- 
ical Physics Application," 
Lawrence Livermore 
National Laboratory, Liver- 
more, California, January 19 
- 28. While there, Meigooni 
collaborated with the Labo- 
ratory's Nuclear Data Group, 
in conjunction with the Med- 
ical Applications Program in 
Livermore, to develop a 
Monte Carlo code for simu- 
lating dose deposition in 
radiation oncology. He 
spoke on "Clinical Applica- 
tions of Radiochromic 
Films" at the Greater St. 
Louis Chapter of the Health 
Physics Society meeting, St. 
Louis, February 3. 
Stephen M. Moerlein, 
Ph.D., associate professor of 
radiology, presented two 
posters, "Compounding of 
[0-15]butanol for PET Blood 
Flow Measurements" (coau- 
thored with Gregory G. 
Gaehle, B.S., scientific 
coordinator; Keith R. Lech- 
ner, B.S., senior medical 
research technician; and 
Michael J. Welch, Ph.D., 
professor of radiology and 
director of the Division of 
Radiation Sciences) and 
"Robotic Preparation of [1- 
nC]acetate for PET Study of 
Diseased Myocardium" 
(coauthored with Gaehle; 
Lechner; Charles S. 
Yahng, B.S., lab assistant; 
and Welch) at the 141st 
Annual Meeting of the Amer- 
ican Pharmaceutical Associ- 
ation, Seattle, March 19 - 23. 
Eduardo G. Moros, Ph.D., 
assistant professor of radiol- 
ogy and chief of hyperther- 
mia physics service, 
presented "Finite Difference 
Model for 3-D Cancer Ther- 
apy with Hyperthermia" 
(coauthored with William L. 
Straube, M.S., instructor in 
radiology, and Robert J. 
Myerson, M.D., Ph.D., 
associate professor of radiol- 
ogy) at the 114th Winter 
Annual Meeting of the Amer- 
ican Society of Mechanical 
Engineers, New Orleans, 
November 28 - December 3. 
Carlos A. Perez, M.D., pro- 
fessor of radiology and 
director of the Radiation 
Oncology Center, spoke on 
"High Dose Rate Brachyther- 
apy for Gynecological Can- 
cers" and "The Present 
Status of Radiation Therapy 
in the Treatment of Cancer" 
at the 11th Asia Pacific Can- 
cer Conference, Bangkok, 
November 16 -19. He pre- 
sented "Radiation Therapy 
for Carcinoma of the Uterine 
Cervix" and "Radiation Ther- 
apy for Carcinoma of the 
Endometrium" at Chiang Mai 
University, Chiang Mai, Thai- 
land, November 20 - 23. 
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James A. Purdy, Ph.D., 
professor of radiology and 
associate director of the 
Radiation Oncology Center, 
as keynote speaker, pre- 
sented "3-D Treatment Plan- 
ning - A New Era in 
Radiotherapy" and lectured 
on "Volume and Dose Speci- 
fications for 3-D CRT" and 
"Multi-Institutional Trials - 
3D CRT Quality Assurance" 
at The Twenty-Ninth Annual 
San Francisco Cancer Sym- 
posium, Washington, D.C., 
February 26 and 27. He 
spoke on "3-D Conformal 
Radiation Therapy: 
Overview of the Washington 
University Experience" at 
the XIth International Con- 
ference for Computers in 
Radiation Therapy, Manches- 
ter, England, March 18 - 24. 
Henry D. Royal, M.D., pro- 
fessor of radiology and asso- 
ciate director of the Division 
of Nuclear Medicine, as 
invited speaker, presented 
"Pulmonary Embolism: Sci- 
entific Challenges" at The 
Eighth Annual Daniel R. 
Biello Memorial Lecture. St. 
Louis, February 14. He 
spoke on "Health Effects of 
Radiation" and "Health 
Effects of the Chernobyl 
Accident" at the Bethesda 
Naval Medical Center, Mary- 
land, March 7. As invited 
lecturer for the 10th H. 
Leonard Warres Lecture, 
Royal spoke on "Technology 
Assessment and Health Care 
Reform: Scientific Chal- 
lenges," University of Mary- 
land Medical System, 
Baltimore, March 17. 
Gregory R. Saboeiro, 
M.D., instructor in radiology 
and a fellow in vascular and 
interventional radiology, 
spoke on "Percutaneous 
Cholecystostomy: Experi- 
ence in 200 Patients" at the 
Society of Cardiovascular 
and Interventional Radiology 
meeting, San Diego, March 
23. 
Stuart S. Sagel, M.D., pro- 
fessor of radiology, chief of 
chest radiology, and cochief 
of body computed tomogra- 
phy, lectured on "Chest Radi- 
ography: Low Technology to 
High Technology" and "Spi- 
ral CT in the Evaluation of 
Thoracic Vascular Disease" 
at the 60th Anniversary Sym- 
posium of the Hellenic Radi- 
ologic Society, Athens, 
Greece, December 11 and 12. 
As visiting professor, he pre- 
sented "Spiral CT in the Tho- 
rax," "CT of Non Vascular 
Mediastinal Masses," and 
"CT of Focal Pulmonary 
Lesions" to the Department 
of Radiology, Bowman Gray 
School of Medicine, Win- 
ston-Salem, January 20 and 
21. As guest lecturer, Sagel 
spoke on "CT of Vascular 
Mediastinal Lesions" at the 
New England Roentgen Ray 
Society, Boston, March 18. 
Janice W. Semenkovich, 
M.D., instructor in radiology, 
presented "Ventilation - Per- 
fusion Imaging: Utility in 
Diagnosis of Non-thrombotic 
Disease," at the Society of 
Thoracic Imaging, Scotts- 
dale, Arizona, March 11. 
Joseph R. Simpson, M.D., 
Ph.D., FACR, associate pro- 
fessor of radiology, pre- 
sented "Salvage Treatment 
for Early Glottic Failure" and 
"Radiotherapeutic Manage- 
ment of Pyrif orm Sinus 
Malignancy" at the Second 
World Congress of Laryngeal 
Cancer, Sydney, Australia, 
February 20 - 24. 
Michael J. Welch, Ph.D., 
professor of radiology and 
chemistry and director of the 
Division of Radiation Sci- 
ences, as guest speaker, pre- 
sented "Cyclotron and PET 
for Developing Countries" at 
the 25th Annual Conference 
of the Society of Nuclear 
Medicine (India) and Annual 
Symposium by The Indo- 
American Society of Nuclear 
Medicine, New Delhi, 
December 14-17. 
O. Clark West, M.D., 
instructor in radiology, pre- 
sented "Trauma Radiogra- 
phy" at the 4th District of the 
Missouri Society of Radio- 
logic Technologists Educa- 
tional Seminar, St. Louis, 
February 5. 
Anthony J. Wilson, M.B., 
Ch.B., associate professor of 
radiology and director of 
emergency radiology, gave a I 
case presentation and spoke I 
on "Ankle Fractures" at Har- I 
borview Hospital, University I 
of Washington, Seattle, Feb- I 
ruary 11. He presented 10 
lectures on "Musculoskeletal | 
Magnetic Resonance Imag- 
ing" at the International 
Diagnostic Radiology 
Course, Davos, Switzerland, 
March 19 - 25. 
Franz J. Wippold, M.D., 
associate professor of radiol- 
ogy, lectured on "Role of 
MRI in Head and Neck Imag- I 
ing," "Imaging the Temporal 
Bone," "Cystic Lesions of the | 
Neck," "Cervical Lym- 
phadenopathy," and "The 
Larynx" at the Head and 
Neck Symposium, Holly- 
wood, Florida, February 4 
and 5. 
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The following Mallinckrodt 
Institute staff members 
(highlighted in boldface 
type) participated in the 
35th Annual Scientific 
Meeting of the American 
Society for Therapeutic 
Radiology and Oncology 
(ASTRO), New Orleans, 
October 11 -15. 
i 
Perry W. Grigsby, M.D., 
chairman, Long Range Plan- 
ning Committee; member, 
Abstract Revew Committee. 
Todd H. Wasserman, M.D., 




Perry W. Grigsby, M.D., 
comoderator, Scientific Ses- 
sion A, "Gynecology -1." 
Todd H. Wasserman, M.D., 
comoderator, Scientific Ses- 
sion T, "Chemical Modifiers." 
Walter R. Bosch, D.Sc; 
Daniel A. Low, Ph.D.; Rus- 
sell L. Gerber, M.S.; Jeff 
M. Michalski, M.D.; Mary 
V. Graham, M.D.; Carlos 
A. Perez, M.D.; William B. 
Harms, B.S.; James A. 
Purdy, Ph.D., "An Elec- 
tronic Viewbox Tool for 
Radiation Therapy Treat- 
ment Verification." 
Bahman Emami, M.D., 
"Phase III Study of Intersti- 
tial Thermoradiotherapy 
Compared with Interstitial 
Radiotherapy Alone in the 
Treatment of Recurrent or 
Persistent Human Tumors: 
A Prospectively Controlled 
Randomized Study by the 
Radiation Therapy Oncology 
Group." 
Mary V. Graham, M.D.; 
Nilesh L. Jain, M.S.*; Michael 
G. Kahn, M.D.*; Robert E. 
Drzymala, Ph.D.; Michael 
A. Mackey, Ph.D.; James 
A. Purdy, Ph.D., "Validation 
and Clinical Usefulness of an 
Objective Plan Evaluation 
Model in the Three-Dimen- 
sional Treatment of Non- 
Small Cell Lung Cancer." 
*Division of Medical Infor- 
matics, Department Of Inter- 
nal Medicine and Depart- 
ment of Computer Science, 
Washington University 
School of Medicine, St. 
Louis. 
Ryuji Higashikubo, Ph.D.; 
Robert S. Malyapa, M.D., 
Ph.D.; Joseph L. Roti Roti, 
Ph.D., "Flow Cytometric 
Studies of SI Nuclease 
Digestion Kinetics and Its 
Application in the Determi- 
nation of Intrinsic Cellular 
Radiation Sensitivity." 
Carlos A. Perez, M.D.; 
Mary V. Graham, M.D.; 
Bahman Emami, M.D.; 
Russell L. Gerber, M.S.; 
John W. Matthews, D.Sc; 
William B. Harms, B.S.; 
James A. Purdy, Ph.D., "A 
Fully Integrated CT-Simula- 
tor: Conceptual Design and 
Clinical Applications." 
James V. Piephoff, M.D.; 
Jeff M. Michalski, M.D.; 
Walter R. Bosch, D.Sc; 
Mary V. Graham, M.D.; 
William B. Harms, B.S.; 
James A. Purdy, Ph.D.; 
Carlos A. Perez, M.D., "A 
Method to Evaluate the 
Impact of Daily Treatment 
Variation on 3-Dimensional 
Dose Distribution." 
Richard Valicenti, M.D.; 
Jeff M. Michalski, M.D.; 
Russell L. Gerber, M.S.; 
Mary V. Graham, M.D.; 
Abel Y. Cheng, M.S.; Wal- 
ter R. Bosch, D.Sc; James 
A. Purdy, Ph.D.; Carlos A. 
Perez, M.D., "Comparison 
of Weekly Port Films and 




Todd H. Wasserman, M.D., 
moderator, "Quality of Life: 




Perry W. Grigsby, M.D.; 
Jonathan A. Haas, B.A.*; 
Barry A. Siegel, M.D., 
"Utility of Pre- and Post- 
Treatment Total Body 1-131 
Scans in Patients with Thy- 
roid Carcinoma." *medical 
student, Washington Univer- 
sity School of Medicine, St. 
Louis. 
Robert J. Myerson, M.D., 
Ph.D.,; Jeff M. Michalski, 
M.D.; Maurice L. King, 
M.D.; Elisa Birnbaum, M.D.*; 
James Fleshman, M.D.*; 
Robert Fry, M.D.*; Ira J. Kod- 
ner, M.D.*; David Lacey, 
M.D.**; Mary Ann Lockett, 
MBA, "Adjuvant Radiation 
Therapy for Rectal Carci- 
noma: Predictors of Out- 
come." *Department of 
Surgery, Washington Univer- 
sity School of Medicine, St. 
Louis. **Department of 
Pathology, Washington Uni- 
versity School of Medicine, 
St. Louis. 
Marie E. Taylor, M.D.; 
Carlos A. Perez, M.D.; 
Karen J. Halverson, M.D.*; 
Robert R. Kuske, M.D.**; 
Robert J. Myerson, M.D., 
Ph.D.; Joseph R. Simpson, 
M.D., Ph.D., "Factors 
Affecting Cosmesis After 
Breast Conservation Ther- 
*Department of Radia- 
tion Oncology, St. Luke's 
Hospital, St. Louis. 
**Department of Radiation 




Perry W. Grigsby, M.D., 
"Carcinoma of the 
Endometrium - Prognostic 
Factors and Management." 
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The following Mallinckrodt 
Institute staff members 
(highlighted in boldface 
type) participated in the 
Ninth Annual Meeting of 
Midwestern Regional Radi- 
ation Research, St. Louis, 
November 12 - 14. 
Joseph L. Roti Roti, Ph.D., 
chairperson, Organizing 
Committee. 
Douglas R. Spitz, Ph.D.; 
Joseph L. Roti Roti, Ph.D., 
members, Program 
Committee. 
Kathy Bles, James Patter- 
son, Naima Sidiqi, mem- 
bers, Local Arrangements 
Committee. 
SYMPOSIUM i: FREE 
RADICAL BIOLOGY 
AND GLUTATHIONE 
Michael A. Mackey, Ph.D., 
chairperson. 
Douglas R. Spitz, Ph.D.; 
John W. Phillips, Ph.D.*; 
Donna T. Adams, B.S.**; C. 
Michael Sherman,**; Dennis 
F. Deen, Ph.D.*; Gloria C. Li, 
Ph.D.*, "Cellular Resistance 
to Oxidative Stress Is 
Accompanied by Resistance 
to Cisplatin: The Signifi- 
cance of Increased Catalase 
Activity and Total Glu- 
tathione in Hydrogen Perox- 
ide-Resistant Fibroblasts." 
*University of California, San 
Francisco. **University of 
Virginia, Charlottesville. 
Douglas R. Spitz, Ph.D.; 
Shannon J. Sullivan, M.D.; 
Michael T. Kintner, Ph.D.*; 
Donna T. Adams, B.S.*; C. 
Michael Sherman, B.S.*; 
Robert J. Roberts, Ph.D.*, 
"Mechanisms of Resistance 
to Oxifative Stress 02-Resis- 




Ming-shun Chen, Ph.D.; 
Albert Fornace, Ph.D.*; 
Andrei Laszlo, Ph.D., 
"Analysis of an HSP 70 
Related Clone from Chinese 
Hamster Cells Suggests that 
It Encodes a 33Kd Protein 
Related to the 67 Kd Protein 
Related to the 67 Kd High 
Affinity Laminin." *National 
Institutes of Health, 
Bethesda. 
Nazan Turkel, M.S.; 
Joseph L. Roti Roti, Ph.D., 
"The Possibility That Incom- 
plete Removal of HMNP 
Could Play a Role in Heat- 
Induced Cellular Lethality." 
Robert P. van der Waal, 
Ph.D.; K. George Thampy, 
Ph.D.; William D. Wright, 
B.S.; Joseph L. Roti Roti, 
Ph.D., "Heat-Induced Modifi- 
cations in the Association of 
Specific Proteins with the 
Nuclear Matrix." 
Ming-shun Chen, Ph.D.; 
Andrei Laszlo, Ph.D., "Dif- 
ferential Expression of Vari- 
ous HSP 70 Family mRNAs 
in Chinese Hamster Cells." 
Andrei Laszlo, Ph.D.; Teri 
Davidson, M.A.; An Hu, 
M.S., "Possible Function of 
the Intercellular Localization 
of HSC 70 in Mammalian 
Cells." 
WORKSHOP I: MODES 
OF CELL DEATH 
Andrei Laszlo, Ph.D., 
chairperson. 
Robert S. Malyapa, M.D., 
Ph.D.; Xiafang Zhang, 
M.D.; Michael A. Mackey, 
Ph.D.; Joseph L. Roti Roti, 
Ph.D., "Characterization of 
Mode of Cell-Death after 
Acute Hyperthermia." 
Michael A. Mackey, Ph.D.; 
Robert S. Malyapa, M.D., 
Ph.D.; Xiafang Zhang, 
M.D., "Mode of Cell Death 
during Long Duration Treat- 
ment of HeLa Cells at 
41.5°C." 
Yvonne C. Taylor, Ph.D.; 
Azemat J. Parsian, B.S., 
"Is the p53-Related Gl Delay 
a Cell Cycle Checkpoint 
(promoting cellular recov- 
ery) or a Cell Cycle Check- 
out Point (representing a 
terminal phenotype) in Irra- 
diated Human Fibroblasts?" 
WORKSHOP II: 
CELL CYCLE DEPEN- 
DENT GENE EXPRES- 
SION AND TUMOR 
SUPPRESSOR GENES 
Prabhat C. Goswami, 
Ph.D.; Clayton R. Hunt, 
Ph.D.; Weihua He, M.S.; 
Joseph L. Roti Roti, Ph.D., 
"Accelerated GrTransit Fol- 
lowing Transient Inhibition 
of DNA Replication-Possible 
Role of GrCyclins." 
Clayton R. Hunt, Ph.D.; 
Prabhat C. Goswami, 
Ph.D.; Weihua He, M.S.; 
Joseph L. Roti Roti, Ph.D., 
"Cell Cycle Regulated 
Expression of Topoiso- 
merase II Is Disrupted by 
Heat and Radiation." 
Yvonne C. Taylor, Ph.D.; 
Azemat J. Parsian, B.S., 
"Alterations in the Nuclear 
(Matrix) Association of 
Tumor Suppressor Gene 
Products in Irradiated 
Human Fibroblasts Undergo-1; 




MATRIX AND RADIA- 
TION REPAIR 
Ryuji Higashikubo, Ph.D.;   I 
Robert S. Malyapa, M.D., 
Ph.D.; Joseph L. Roti Roti, | 
Ph.D., "SI Nuclease Diges- 
tion Kinetics and Its Applica-1 
tion in the Determination of I 
Intrinsic Cellular Radiation 
Sensitivity." 
William D. Wright, B.S.; 
Robert S. Malyapa, M.D., 
Ph.D.; Joseph L. Roti Roti, 1 
Ph.D., "Nuclear Matrix Pro- 
tein Content and DNA Loop 





The following Mallinckrodt 
Institute staff members 
(highlighted in boldface 
type) participated in the 
79th Scientific Assembly 
and Annual Meeting of the 
Radiological Society of 
North America (RSNA), 




R. Gilbert Jost, M.D., pre- 
siding, "The All-Digital Radi- 
ology Department: Is It Just 
Around the Corner?" 
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IMAGING SYMPOSIUM - 
SPIRAL (HELICAL) CT: 
PRINCIPLES, TECH- 
NIQUES, AND CLINI- 
CAL APPLICATIONS 
James A. Brink, M.D., panel 
member, "Principles and Tech- 
nical Considerations." 
Jay P. Heiken, M.D., panel 
member, "Abdominal Appli- 




Stuart S. Sagel, M.D., "Oral 
Presentation of Research." 
REFRESHER COURSES 
Dennis M. Balfe, M.D.; 
William E. Torres, M.D.*, 
"Incidental Liver Lesion." 
*Emory University, Atlanta, 
Ronald G. Evens, M.D.; 
Jonathan Sunshine, Ph.D.*, 
"Managed Competition: Cur- 
rent Major Proposal from the 
Clinton Administration." 
*American College of Radiol- 
ogy, Reston, Virginia. 
Jay P. Heiken, M.D.; Janet 
I   E. S. Husband, FRCP, FRCR*, 
"CT and MR Imaging of Pelvic 
Neoplasms." *Royal Marsden 
Hospital, Sutton, England. 
Marshall E. Hicks, M.D.; 
Michael D. Dake, M.D.*, "Per- 
cutaneous Endovascular 
Recanalization Techniques 
for the Treatment of Chronic 
Occlusive Vascular Disease." 
*Department of Radiology, 
Stanford University. 
William H. McAlister, 
M.D.; Alan S. Brody, M.D.*, 
"Pediatric Imaging: 
Paranasal Sinuses and Nasal 
Cavities." *Department of 
Radiology, Children's Hospi- 
tal of Buffalo. 
Jeff M. Michalski, M.D.; 
John W. Wong, Ph.D.*, "Real- 
Time Portal Imaging." 
*William Beaumont Hospital, 
Royal Oak, Michigan. 
William D. Middleton, 
M.D., "US of the Male Repro- 
ductive System - Testes and 
Scrotum." 
Barbara S. Monsees, M.D.; 
Judy M. Destouet, M.D.*, 
"Practical Aspects of Per- 
forming Screening Mammog- 
raphy." *Private practice, 
Baltimore. 
Barbara S. Monsees, M.D., 
panel member, "Imaging of 
the Surgically Altered 
Breast." 
Robert J. Myerson, M.D., 
Ph.D.; Leonid B. Leybovich, 
Ph.D.*, "Improved Methods 
of Hyperthermia Delivery." 
*Loyola Medical Center, 
Naperville. 
Daniel Picus, M.D.; Timo- 
thy C. McCowan, M.D.*; 
Michael J. Pentecost, M.D.**, 
"Venous Thromboembolic 
Disease: Fibrinolytic Ther- 
apy and Inferior Vena Cava 
Filters." *Department of 
Radiology, University of 
Nebraska, Omaha. **Depart- 
ment of Radiology, Univer- 
sity of Pennsylvania, 
Philadelphia. 
Henry D. Royal, M.D., 
"Effects of Low-Level Radia- 
tion: Scientific, Political, 
and Social Views." 
Stuart S. Sagel, M.D.; 
Elliot K. Fishman, M.D.*; 
Patrick F. Sheedy, M.D.**, 
"Fast CT Scanning: Clinical 
Applications of Spiral and 
Electro-Beam CT." *Depart- 
ment of Radiology, Johns 
Hopkins Hospital, Baltimore. 
**Department of Diagnostic 
Radiology, Mayo Clinic, 
Rochester. 
Marilyn J. Siegel, M.D.; 
George S. Bisset, M.D*, 
"Pediatric Body CT and MR: 
Problem Areas and Pitfalls." 




Louis A. Gilula, M.D., 
comoderator, "Categorical 
Course in Musculoskeletal 
Radiology Advanced Imaging 
of Joints: Theory and Prac- 
tice - General Principles," 
"Categorical Course in Mus- 
culoskeletal Radiology 
Advanced Imaging of Joints: 
Theory and Practice - The 
Wrist, Specialized Plain 
Films and CT Scanning: 
Techniques, Indications, and 
Findings," "Categorical 
Course in Musculoskeletal 
Radiology Advanced Imaging 
of Joints: Theory and Prac- 
tice - The Elbow and Shoul- 
der," "Categorical Course in 
Musculoskeletal Radiology 
Advanced Imaging of Joints: 
Theory and Practice - The 
Hip," "Categorical Course in 
Musculoskeletal Radiology 
Advanced Imaging of Joints: 
Theory and Practice - The 
Knee," and "Categorical 
Course in Musculoskeletal 
Radiology Advanced Imaging 
of Joints: Theory and Prac- 
tice - The Foot and Ankle." 
WORKSHOPS 
WiUiam D. Middleton, 
M.D.; Mitzi Fields, RDMS.*; 
Kevin P. Lee, CRT, RDMS**; 
Philip W. Rails, M.D.**; 
Ronald R. Townsend, 
M.D.***; Laurence A. Mack, 
M.D.****; Edward G. Grant, 
M.D.**, "Practical Abdominal 
Color Doppler ("Hands-on" 
Workshop)." *University of 
Alabama, Birmingham. 
**University of Southern Cal- 
ifornia - Los Angeles Campus 
Medical Center. ***Division 
of Body Imaging, University 
of Colorado Health Sceinces 
Center, Denver. ****Depart- 
ment of Radiology, Univer- 




Michael D. Darcy, M.D., 
presiding, Scientific Sessions 
- Cardiovascular. 
Harvey S. Glazer, M.D., 
program committee member, 
Chest Radiology. 
Jay P. Heiken, M.D., pre- 
siding, Scientific Sessions - 
General (CT). 
Bruce L. McClennan, 
M.D., chairman, program 
committee, Genitourinary 
Radiology. 
Barry A. Siegel, M.D., pre- 
siding, Scientific Sessions - 
Nuclear Medicine (PET, 
Oncology). 
Todd H. Wasserman, M.D., 
program committee member, 
Radiation Oncology/ 
Radiobiology. 
Anthony J. Wilson, M.B., 
Ch.B, presiding, Scientific 
Sessions - Bone (MR Imaging 
and Spectroscopy). 
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D. Claire Anderson, M.D.; 
Harvey S. Glazer, M.D.; 
Janice W. Semenkovich, 
M.D.; Joel D. Cooper, M.D.*: 
R. Sudhir Sundaresan, M.D.*; 
G. Alec Patterson, M.D.*, 
"Chest Radiography after 
Lung Transplantation: First 
10 Days." *Department of 
Surgery, Washington Univer- 
sity School of Medicine, St. 
Louis. 
James A. Brink, M.D.; 
Lane A. Deyoe, M.D.; Jay 
P. Heiken, M.D.; Ge Wang, 
Ph.D.; Roberta L. Yoffie, 
R.T.; Michael W. Vannier, 
M.D., "Spiral CT Angiogra- 
phy for Renal Arterial Steno- 
sis: In Vitro Assessment of 
Technical Parameters." 
Clifford K.S. Chao, M.D.; 
Mary V. Graham, M.D.; 
Daniel A. Low, Ph.D.; 
Todd H. Wasserman, M.D., 
"Three-dimensional CT- 
derived Model for Estimating 
Lung Volume Irradiated from 
Simulation Films." 
Thomas E. Conturo, M.D., 
Ph.D.; John D. Strandberg, 
Ph.D., D.V.M.*; Brian J. 
Soher, B.E.E.*; Peter B. 
Barker, D. Phil*; James H. 
Anderson, Ph.D.*, "Assess- 
ment of Tumor Perfusion 
and Blood-Brain-Barrier 
Leakage with Phase- 
enhancement Effects of Con- 
trast Agents." *Johns 
Hopkins Hospital, Baltimore. 
Michael D. Darcy, M.D.; 
Daniel Picus, M.D.; 
Thomas M. Vesely, M.D.; 
Marshall E. Hicks, M.D.; 
Leanna Dick, M.D.*; Mark 
Mayhle, M.D.**; et al, "Effi- 
cacy and Complications of 
Transjugular Intrahepatic 
Portosystemic Shunts." 
*Durham Radiology Associ- 
ates, Durham, North Car- 
olina. **Rock Hill Radiol- 
ogists, Raytown, Missouri. 
Michael D. Darcy, M.D.; 
Darryl Zuckerman, M.D.*; 
Daniel Picus, M.D.; 
Thomas M. Vesely, M.D.; 
Marshall E. Hicks, M.D.; 
Thomas Bocchini, M.D.*, 
"Evaluation of Risk Factors 
for Development of 
Encephalopathy after Tran- 
sjugular Intrahepatic Por- 
tosystemic Shunt 
Placement." *Saint Louis 
University, St. Louis. 
Gopal R. Desai, M.D.; 
Ryuji Higashikubo, Ph.D.; 
David L. Lacey, M.D.*; 
Manuel Ribero, M.D.**; 
Robert J. Myerson, M.D., 
Ph.D.; Ira J. Kodner, 
M.D.***; et al, "Predictive 
Assays in the Therapy of 
Carcinoma of the Rectum 
Treated with Preoperative 
Radiation and Correlation 
with Clinical Outcome." 
*Department of Pathology, 
Washington University 
School of Medicine, St. 
Louis. **Department of 
Surgery, Rua Augusto Lessa, 
Portugal. ***Department of 
Surgery, Washington Univer- 
sity School of Medicine, St. 
Louis. 
Richard N. Edelstein, 
M.D.; Shawn P. Quillin, 
M.D.; Bruce L. McClennan, 
M.D., "Urethrographic Eval- 
uation after Penile Gunshot 
Wounds." 
Howard P. Forman, M.D.; 
James A. Brink, M.D.; 
Dennis M. Balfe, M.D.; 
Frank J. Schlueter, M.D.; 
Jay P. Heiken, M.D., "Posi- 
tive-contrast Spiral CT 
Cholangiography Following 
Oral Administration of Cal- 
cium Ipodate: Feasibility 
Study." 
Lee A. Fox, B.S.*; Michael 
W. Vannier, M.D.; O. Clark 
West, M.D.; Anthony J. 
Wilson, M.B., Ch.B; Gregg 
A. Baran, M.D.**; Thomas 
K. Pilgram, Ph.D., "Imaging 
of Midfacial Fractures: Com- 
parative Study of Spiral CT, 
3D Reconstructions, and 
Multiplanar Reformations." 
*medical student, Washing- 
ton University School of 
Medicine, St. Louis. **Pri- 
vate practice, St. Petersburg, 
Florida. 
Harvey S. Glazer, M.D.; 
Janice W. Semenkovich, 
M.D.; D. Claire Anderson, 
M.D.; Elbert P. Trulock, 
M.D.*; G. Alec Patterson, 
M.D.**; Joel D. Cooper, 
M.D.**, "Complications in 
the Native Lung Following 
Single-Lung Transplanta- 
tion." *Department of Inter- 
nal Medicine, Washington 
University School of Medi- 
cine, St. Louis. **Depart- 
ment of Surgery, Washington 
University School of Medi- 
cine, St. Louis. 
Carolyn A. Haerr, M.D.; 
Louis A. Gilula, M.D.; 
Frederick A. Mann, M.D.*; 
Yuming Yin, M.D.; Claus F. 
Larsen, M.D., Ph.D.**, "Accu- 
rate Assessment of the 
"True" Neutral Posteroante- 
rior and Lateral Projections 
of the Wrist: Importance of 
Determining Ulnar Vari- 
ance." *Department of Radi- 
ology, Harborview Hospital, 
University of Washington 
Medical Center, Seattle. ** 
Odense University Hospital, 
Odense, Denmark. 
Jay P. Heiken, M.D.; James 
A. Brink, M.D.; Bruce L. 
McClennan, M.D.; Stuart 
S. Sagel, M.D.; Tamara M. 
Crowe, R.T.; Mary Virginia i 
Gaines, B.S., "Dynamic Con- 
trast-enhanced CT of the 
Liver: Comparison of Vol- 
umes and Concentrations of 
Contrast Media." 
Daniel Keleti, M.D.; 
V. Rao Devineni, M.D.*, 
"Esoph-ageal Stricture: Sur- 
veillance of 20 Cases and a 
Review of the Literature." 
*Department of Radiation 
Oncology, DePaul Health 
Center, St. Louis. 
Benjamin C. P. Lee, M.D.; 
T. S. Park, M.D.*; Bruce A. 
Kaufman, M.D.*, "Single- 
Voxel Proton Spectroscopy 
of Pediatric Brain Tumors." 
*Department of Neurological 
Surgery, Washington Univer- 
sity School of Medicine, 
St. Louis. 
Henry K. Lee, M.D.; 
Ganesh Ramachandran, 
B.S.; Perry W. Grigsby, 
M.D.; Ernesto Molmenti, 
M.D.; Allison Buckner, 
B.S.; Rahman Emami, M.D., 
"Prognostic Factors for Papil- 
lary and Follicular Thyroid 
Carcinoma: Findings at 
Long-term Follow-up." 
Debiao Li, Ph.D.; E. Mark 
Haacke, Ph.D.; Tasneem N. 
Khimji, M.D.*; David Miller*, 
"MR Angiography of the 
Renal Arteries with IR and 
Fat Saturation Techniques." 
*Case Western Reserve 
University, Cleveland. 
Gary D. Luker, M.D.; Mari- 
lyn J. Siegel, M.D., "Scrotal 
and Testicular Enlargement 
in Pediatric Patients: Evalua- 
tion with Color Doppler US.' 
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Charles T. McConnell, Jr., 
M.D.; Mokhtar H. Gado, 
M.D.; Benjamin C.P. Lee, 
M.D.; Daniel K. Kido, 
M.D.; Michael G. Crowley, 
Ph.D., "Evaluation of the 
Clinical Utility of Fast SE in 
Single- and Dual-Contrast 
Modes." 
Charles T. McConnell, Jr., 
M.D.; Joseph F. Plouffe, 
M.D.*; Thomas M. File, 
M.D.**; Charles F. Mueller, 
M.D.*; Barbara J. Marston, 
M.D.***; Robert F. Breiman, 
M.D.***, "Radiographic Man- 
ifestations of Chlamydia 
pneumoniae Pneumonia." 
*Ohio State University, 
Columbus. **Akron City 
Hospital, Akron. ***Centers 
for Disease Control, Atlanta. 
Eric S. Maiden, M.D.; 
Daniel Picus, M.D.; 
Thomas M. Vesely, M.D.; 
Michael D. Darcy, M.D.; 
Marshall E. Hicks, M.D., 
"Comparison of Stepping 
DSA with Conventional 
Screen-Film Angiography for 
Evaluation of Peripheral Vas- 
cular Disease." 
Mary A. Middleton, M.D.; 
William D. Middleton, 
M.D.; Meaghan M. O'Connor, 
M.D.*; David Keetch, M.D.*; 
Steve M. Dierks, M.D.*, 
"Sonographic Prediction of 
Viability in Testicular Tor- 
sion." *Division of Urologic 
Surgery, Washington Univer- 
sity School of Medicine, St. 
Louis. 
Robert J. Myerson, M.D., 
Ph.D.; Jeff M. Michalski, 
M.D.; Maurice L. King, 
M.D.; Elisa Birnbaum, M.D.*; 
James Fleshman, M.D.*; 
Robert Fry, M.D.*; et al, 
"Adjuvant Radiation Therapy 
for Rectal Carcinoma: Pre- 
dictors of Outcome." 
*Department of Surgery, 
Washington University 
School of Medicine, St. 
Louis. 
Timothy R. O'Leary, M.D.; 
Todd H. Wasserman, M.D.; 
Nancy A. Kucik, clinical 
research associate, 
"Treatment of Localized 
Supradiaphragmatic Interme- 
diate-Grade Non-Hodgkin 
Lymphoma with Radiation 
Therapy Alone: Tumor Size 
as a Selection Factor." 
Shawn P. Quillin, M.D.; 
Marilyn J. Siegel, M.D., 
"Efficacy of Color Doppler 
Sonography for Appendici- 
tis," "Color Doppler US of 
Painful Ovary in Adoles- 
cents," "Gastrointestinal 
Inflammation: Color Doppler 
US," and "Posttransplanta- 
tion Lymphoproliferative Dis- 
orders in Children: Intra- 
abdominal Manifestations." 
Cynthia K. Rigsby, M.D.; 
Marilyn J. Siegel, M.D., 
"Patterns of Perirenal Spread 
of Wilms Tumor." 
Frank J. Schlueter, M.D.; 
Ge Wang, Ph.D.; Paul S. 
Hsieh, M.D.*; James A. 
Brink, M.D.; Michael W. 
Vannier, M.D., "Improved 
Longitudinal Axis Resolution 
in Spiral CT by Means of 
Deconvolution Techniques." 
*Department of Radiology, 
Cedars-Sinai Medical Center, 
Los Angeles. 
Janice W. Semenkovich, 
M.D.; Harvey S. Glazer, 
M.D.; D. Claire Anderson, 
M.D.; Joseph M. Arcidi, 
M.D.*; Frank J. Schlueter, 
M.D.; G. Alec Patterson, 
M.D.**, "CT Follow-up of 
Bronchial Anastomotic Com- 
plications after Lung Trans- 
plantation." *Cleveland 
Clinic Foundation, Cleve- 
land. **Department of 
Surgery, Washington Univer- 
sity School of Medicine, St. 
Louis. 
Felix L. Song, M.D.; 
William D. Middleton, 
M.D.; Thomas C. Winter, 
M.D.*; Paul E. Swanson, 
M.D.**; Laurence A. Mack, 
M.D.*, "Association Between 
Intratubular Germ Cell Neo- 
plasia and Testicular 
Microlithiasis." *University 
of Washington, Seattle. 
**Department of Pathology, 
Washington University 
School of Medicine, St. 
Louis. 
Kirk E. Smith, AAS; Gulab 
H. Bhatia, MSEE; Michael 
W. Vannier, M.D., "Assess- 
ment of Mass Properties of 
the Human Head with Use of 
Different 3D Imaging 
Modalities." 
Richard K. Valicenti, M.D.; 
Todd H. Wasserman, M.D.; 
Nancy A. Kucik, clinical 
research associate, 
"Whole-Abdomen Irradiation 
in Abdominal Non-Hodgkin 
Lymphoma Patients." 
Michael W. Vannier, M.D.; 
Paul K. Commean, B.S.; 
Gulab H. Bhatia, MSEE; 
Kirk E. Smith, AAS, "Vali- 
dation of Spiral CT and Opti- 
cal Surface Scanning for Use 
in 3D Design of Limb 
Prosthesis." 
Ge Wang, Ph.D.; Michael 
W. Vannier, M.D., "Spiral 
CT Image Noise: Analytic 
Results." 
Ge Wang, Ph.D.; Michael 
W. Vannier, M.D.; Roberta 
L. Yoffie, R.T., "StairStep 
Artifacts in Spiral CT: A 
Phantom Study." 
O. Clark West, M.D.; Stuart 
E. Mirvis, M.D.*; Kathirka- 
manathan Shanmuganathan, 
M.D.*, "CT Patterns of 
Transsphenoidal Basilar 
Skull Fractures." *University 




Benjamin C. P. Lee, M.D.; 
Edward C. Angtuaco, M. 
D.; Robert C. Wood, M.D.; 
Daniel K. Kido, M.D.; 
Michael G. Crowley, 
Ph.D., "Frequency-selective 
Fat-Suppression: Principle 
and Clinical Applications in 
the Spine." 
Kevin W. McEnery, M.D.; 
Anthony J. Wilson, M.B., 
Ch.B; William A. Murphy, 
Jr., M.D.*, "Comparison of 
Standard and Spiral CT in 
the Evaluation of Wrist 
Trauma." *Division of Diag- 
nostic Imaging, M.D. Ander- 
son Cancer Center, Houston. 
Kevin W. McEnery, M.D.; 
Anthony J. Wilson, M.B., 
Ch.B; William A. Murphy, 
Jr., M.D.*, "Spiral CT Evalua- 
tion of Musculoskeletal 
Trauma." *Division of Diag- 
nostic Imaging, M.D. Ander- 
son Cancer Center, Houston. 
L. Santiago Medina, M.D.; 
Marilyn J. Siegel, M.D.; 
Pablo A. Bejarano, M.D.*, 
cum laude award for "Imag- 
ing and Pathologic Correla- 
tion in Pediatric Lung 
Transplantation." *Depart- 
ment of Pathology, Washing- 
ton University School of 
Medicine, St. Louis. 
Stuart E. Mirvis, M.D.*; 
Kathirkamanathan Shanmu- 
ganathan, M.D.*; Charles S. 
White, M.D.*; O. Clark 
West, M.D.; Michael I. Roth- 
man, M.D.*; Greg H. Zoarski, 
M.D.*; "Current Concepts in 
Trauma Imaging." ♦Univer- 
sity of Maryland Medical Sys- 
tem, Baltimore. 
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Allen B. Oser, M.D.; Ben- 
jamin C. P. Lee, M.D.; 
Daniel K. Kido, M.D.; 
Michael G. Crowley, Ph.D., 
"Two-dimensional and 3D 
High-Resolution Turbo SE of 
the Temporal Bone." 
Shawn P. Quillin, M.D.; 
Lane A. Deyoe, M.D.; 
William D. Middleton, 
M.D.; Michael D. Darcy, 
M.D.; Sharlene A. Teefey, 
M.D.; James A. Brink, M.D., 
"Evaluation of Doppler Crite- 




Richard M. Slone, M.D., 
"Reproducing Radiographs 
from Slides." 
Richard M. Slone, M.D.; 
Karl E. Weingarten, M.D.*, 
"Skeletal Disease Findings on 
Chest Radiographs." Univer- 
sity of Florida, Gainesville. 
Nhan P. Truong, M.D.*; Wil- 
fred C. Peh, M.D.; William 
G. Totty, M.D.; Louis A. 
Gilula, M.D., "MR Imaging of 
Soft-Tissue Masses around 
the Hand and Wrist." *St. 
Francis Hospital, Tulsa. 
Nhan P. Truong, M.D.*; Fred- 
erick A. Mann, M.D.**; Louis 
A. Gilula, M.D.; Si-Won 
Kang, M.D.***, "Tailored 
Wrist Instability Series and Its 
Cost-effectiveness." *St. 
Francis Hospital, Tulsa. 
**Department of Radiology, 
Harborview Hospital, Univer- 
sity of Washington Medical 
Center, Seattle. ^Depart- 
ment of Radiology, Dae-Jeon 
St. Mary's Hospital, Catholic 
University Medical College, 
Dae-Jeon, Korea. 
Nhan P. Truong, M.D.*; 
William G. Totty, M.D.; 
Louis A. Gilula, M.D., "Tai- 
lored Imaging Approach to 
Ankle Tendon and Tendon 
Sheath Disease." *St. Francis 
Hospital, Tulsa. 
Yuming Yin, M.D.; Wang 
Yun Zhao, M.D.; Anthony 
J. Wilson, M.B., Ch.B; 
Louis A. Gilula, M.D., 
"Endemic Fluorosis of Bone: 
A Disorder with Diverse 
Appearance." 
INFORAD EXHIBITS 
R. Gilbert Jost, M.D., mem- 
ber, Electronic Communica- 
tions Committee. 
Stephen M. Moore, M.S.; 
G. James Blaine III, D.Sc; 
David E. Beecher, M.S.; 




Robert Hindel, Ph.D., 
cochairman*; G. James 
Blaine III, D.Sc, cochair- 
man; et al**, "Implementation 
of the DICOM 3.0 Standard." 
* chairman, National Electri- 
cal Manufacturers Associa- 
tion (NEMA) MedPacs; 
representative for Philips 
Medical Systems; president 
of RH Consulting. **other 
representatives affiliated 
with University of Oldenburg, 
Germany; Merge Technolo- 
gies Inc.; Kodak Health Imag- 
ing Systems; Pennsylvania 




R. Gilbert Jost, M.D., 
"Wide Band Networks: Their 
Importance for Radiology." 
FILM INTERPRETA- 
TION SESSION 
L. Santiago Medina, M.D., 
first place award. 
HONORS/ 
AAARDS 
Clifford K.S. Chao, M.D., 
instructor in radiology, 
received the 1993 Resident 
Assay Award from the 
American Endocuritherapy 
Society for his paper, 
"Brachytherapy Related 
Medical Complication in 
Medical Inoperable Stage I 
Endometrial Carcinoma." 
William H. McAlister, 
M.D., professor of radiology 
and chief of pediatric 
radiology, and Alan E. 
Schlesinger, M.D., assistant 
professor of radiology, as 
invited participants, attended 
the American College of 
Radiology Videodisc Team, 
February 10 -12, in Los 
Angeles. The videodisc con- 
tains several thousand cases, 
covering all aspects of pedi- 
atric radiology. McAlister 
and Schlesinger developed 
segments on gastrointestinal 
tract, liver, spleen, and pan- 
creas. The ACR plans to 
offer the videodisc for sale in 
late 1994 or 1995. The disc 
material is geared for senior 
residents studying for 
Boards, for pediatric radiolo- 
gists taking the Certificate of 
Added Qualifications Exami- 
nation, and for any practic- 
ing radiologist who wants to 
use the videodisc format to 
learn more about pediatric 
radiology. 
Bruce L. McClennan, M.D., 
professor of radiology and 
chief of abdominal radiology, 
collaborated on the develop- 
ment of an American College I 
of Radiology video on the 
mistaken use of ionic con- 
trast agent for myelography. 
The tape will be sent to all 
radiologists and to all hospi- 
tals where myeolography is 
performed. 
Carlos A. Perez, M.D., pro- 
fessor of radiology and direc- 
tor of the Radiation 
Oncology Center, received 
the 1993 Distinguished Alum- 
nus Award from M.D. Ander- 
son Cancer Center, Houston, 
where he completed a radia- 
tion therapy fellowship in 
1964. At the award cere- 
monies on October 1, Perez 
spoke on "Carcinoma of the 
Uterine Cervix: Past, Pre- 
sent, and Future." 




Joseph L. Roti Roti, 
Ph.D., professor of radiol- 
ogy, associate director of 
the Radiation Oncology Cen- 
ter, and chief of the cancer 
biology section, as principal 
investigator, received a $2.4 
million grant from the 
Motorola Corporation for 
"Research on the Biological 
Effects of Non-ionizing Elec- 
tromagnetic Radiation." 
Coinvestigators are Michael 
A. Mackey, Ph.D., assistant 
professor of radiology, and 
Eduardo G. Moros, Ph.D., 
assistant professor of radiol- 
ogy and chief of hyperther- 
mia physics service. 
Marilyn J. Siegel, M.D., 
professor of radiology, 
received a $249,728 National 
Cancer Institute grant for the 




R. Gilbert Jost, M.D., pro- 
fessor of radiology and chief 
of the Division of Diagnostic 
Radiology, was again named 
one of three organizers of 
Medical Imaging 1994, held 
February 13 -18 in Newport 
Beach with more than 1,000 
attendees. The Society of 
Photo-Optical Instrumenta- 
tion Engineers annual sym- 
posium comprises six 
separate digital imaging con- 
ferences. Jost also chaired 
and organized one of the 
symposium's four-day con- 
ferences — "PACS: Design 
and Evaluation." 
Eric Klein, M.S., instructor 
in radiology, was elected to a 
two-year term (1994-1996) 
on the Board of Directors of 
the American Association of 
Physicists in Medicine 
(AAPM). He was named to 
the AAPM's Training of Radi- 
ologists Committee for 1994- 
1996. 
Ali S. Meigooni, Ph.D., 
assistant professor of radiol- 
ogy, was appointed to the 
American Association of 
Physicists in Medicine 
(AAPM) Radiochromic Film 
Dosimetry Task Group 55. 
He was named to the faculty 
of the 1994 AAPM Summer 
School to be held at the Uni- 
versity of California, San 
Diego. 
Joel S. Perlmutter, M.D., 
associate professor of neu- 
rology and radiology, was 
appointed chairman of the 
External Review Committee 
to Evaluate the Intramural 
Neuroimaging Program at 
the National Institute of 
Mental Health. 
CALENDAR 
April 9 - 13, 1994 
American Society of Emer- 
gency Radiology 
Orlando 
April 24 - 29, 1994 
94th Annual Meeting of the 
American Roentgen Ray 
Society 
New Orleans 
June 5 - 8, 1994 
Society of Nuclear Medicine 
Annual Meeting 
Orlando 
June 12 - 15, 1994 
Computer Applications in 
Radiology 
Winston-Salem 
June 14 - 18, 1994 
American College of Medical 
Physicists Annual Meeting 
Jackson Hole 
July 24 - 28, 1994 
American Association of 
Physicists in Medicine 
Annual Meeting 
Anaheim 





Meeting of RSNA 
1 Michel Ter-Pocossian, Ph.D„ and 
Anica JovanovR, M.D., who was 
MIR's first female resident. 
2 (left to right) Jeff Micbalski, 
M.D.; Robert Kuske, M,D.; and 
Joseph Simpson, M.D., Ph.D. 
3 (left to right) Robert Koehler, 
M.D.; Helen Totty; Ellen Vannier; 
and Michael Vannier, M.D. 
4 (left to right) Jonas Singer, M.O.; 
Juan Taveras, M.D.; Ronald Evens, 
M.D.; Meredith Ragsdale; and 
Edward Ragsdale, M.O. 
5 (left to right) Ben Mayes, M.D.; 
John Armstrong, MA, M.D.; Ellen 
Mayes; and Jim Winthrop, M.D. 
6 (left to right) L Santiago Medina, 
M.D.; Edda Quintero, M.D.; Lee Fox, 
Washington University School of 
Medicine student; and Louis Gilula, 
M.D. 
7 (left to right) Bruce Bower, M.D., 
1988-89 cochief resident; William       5 
Horstman, M.D., 1991-92 cocMef 
resident; and Michael Katz, M.D. 
8 Patti Lester; Pat Lester, M.D.; 
Ronald Evens, M.D.; Hanna Evens; 
Robert Stanley, M.D.; and Sally 
Stanley. 
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Daniel Keleti, M.D., (left) and James V. Piephoff, M.D., are the 1993-1994 tochief 
and chief resident, respectively, of the Radiation Oncology Center. 
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